Multi-country #outbreak of #monkeypox – #SitRep 3, 10 August 2022 (@WHO, excerpts: 27,814 cases, 11 deaths)

Risk assessment:

** Global risk – Moderate

WHO Regional risk:

European Region – High

African Region, Region of the Americas, Eastern Mediterranean Region,
Southeast Asia Region – Moderate

Western Pacific Region – Low-Moderate

Laboratory confirmed cases: 27 814

Deaths: 11

Countries/areas/territories: 89

Highlights

• For the first time, monkeypox deaths have been reported in countries outside of the African Region in Spain (two deaths), Brazil (one death), and India (one death). In two cases, deaths have been linked to viral encephalitis and some patients had underlying immune compromising conditions.

• On 8 August, WHO convened a meeting of two WHO Collaborating Centres for orthopoxviruses and other experts in poxvirology and viral evolution to consider the naming of monkeypox virus (MPXV) variants.

Alternate names for monkeypox are being collected on the ICD proposal platform and suggestions are welcome. There are other processes on-going for the renaming of the virus itself and its clades.

• On 20 July 2022, WHO launched a global epidemiological report titled “Multi- Country Monkeypox Outbreak – Global Trends” to provide detailed epidemiological information from case report forms provided by the Member States to WHO. A new section highlighting the situation in West and Central Africa was added on 28 July.

• Vaccination programmes for monkeypox should be accompanied by strong information campaigns conveying that it takes approximately two weeks from completion of a vaccination series (one or two doses depending on product) for immunity to fully develop. The level of protection conferred by vaccination under different circumstances has not yet been determined for this outbreak. For these reasons, people from the most affected communities where monkeypox is present should continue to take protective measures during this outbreak. This may include temporarily reducing the number of sexual partners to reduce potential exposure.

• WHO urges countries to scale up their response, and to implement the recommendations included in the declaration of the Public Health Emergency of International Concern, to bring the outbreak under control.

(…)

Source: World Health Organization, external URL: https://www.who.int/publications/m/item/multi-country-outbreak-of-monkeypox–external-situation-report–3—10-august-2022

#Coronavirus Disease Research References (by AMEDEO, August 7 ’22)

1. SINNBERG T, Lichtensteiger C, Hasan Ali O, Pop OT, et al.

Pulmonary Surfactant Proteins are Inhibited by IgA Autoantibodies in Severe

COVID-19.

Am J Respir Crit Care Med. 2022 Aug 4. doi: 10.1164/rccm.202201-0011.

PubMed: http://www.amedeo.com/p2.php?id=35926164&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35926164

2. MUNGMUNPUNTIPANTIP R, Wiwanitkit V.

CoronaVac or BNT162b2 Vaccine as a Third Dose.

Am J Respir Crit Care Med. 2022;206:360-361.

PubMed: http://www.amedeo.com/p2.php?id=35561336&s=cov&pm=2

Share: http://m.amedeo.com/35561336

3. MONTORI VM.

Patients surviving COVID-19 had increased risk for incident diabetes vs. persons

without COVID-19.

Ann Intern Med. 2022 Aug 2. doi: 10.7326/J22-0052.

PubMed: http://www.amedeo.com/p2.php?id=35914265&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35914265

4. BROPHY JM.

mRNA COVID-19 vaccines were linked to myocarditis at 28 d (0.15 to 10 excess

events/100 000 vaccinated persons).

Ann Intern Med. 2022 Aug 2. doi: 10.7326/J22-0057.

PubMed: http://www.amedeo.com/p2.php?id=35914261&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35914261

5. AISENBERG GM.

In persons at risk for poor vaccination response or COVID-19 exposure,

tixagevimab + cilgavimab reduced COVID-19.

Ann Intern Med. 2022 Aug 2. doi: 10.7326/J22-0056.

PubMed: http://www.amedeo.com/p2.php?id=35914259&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35914259

6. SALOMON JA, Bilinski A.

Evaluating the Performance of Centers for Disease Control and Prevention COVID-19

Community Levels as Leading Indicators of COVID-19 Mortality.

Ann Intern Med. 2022 Aug 2. doi: 10.7326/M22-0803.

PubMed: http://www.amedeo.com/p2.php?id=35914253&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35914253

7. ELLIS SJ.

Covid-19 impact on patients: ease of access should be a clear aim of the NHS.

BMJ. 2022;378:o1941.

PubMed: http://www.amedeo.com/p2.php?id=35926879&s=cov&pm=2

Share: http://m.amedeo.com/35926879

8. MAHASE E.

Covid-19: One in eight adults develops long covid symptoms, study suggests.

BMJ. 2022;378:o1946.

PubMed: http://www.amedeo.com/p2.php?id=35926861&s=cov&pm=2

Share: http://m.amedeo.com/35926861

9. WARD IL, Bermingham C, Ayoubkhani D, Gethings OJ, et al.

Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with

delta (B.1.617.2): retrospective cohort study.

BMJ. 2022;378:e070695.

PubMed: http://www.amedeo.com/p2.php?id=35918098&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35918098

10. LORENZO-REDONDO R, Ozer EA, Hultquist JF.

Covid-19: is omicron less lethal than delta?

BMJ. 2022;378:o1806.

PubMed: http://www.amedeo.com/p2.php?id=35918084&s=cov&pm=2

Share: http://m.amedeo.com/35918084

11. DYER O.

Covid-19: Ontario hospitals close wards as nursing shortage bites.

BMJ. 2022;378:o1917.

PubMed: http://www.amedeo.com/p2.php?id=35914798&s=cov&pm=2

Share: http://m.amedeo.com/35914798

12. HERETH B, Tubig P, Sorrels A, Muldoon A, et al.

Long covid and disability: a brave new world.

BMJ. 2022;378:e069868.

PubMed: http://www.amedeo.com/p2.php?id=35914783&s=cov&pm=2

Share: http://m.amedeo.com/35914783

13. GRIFFIN S.

Covid-19: Staff absences in July surged amid ongoing pressure on hospitals.

BMJ. 2022;378:o1909.

PubMed: http://www.amedeo.com/p2.php?id=35914777&s=cov&pm=2

Share: http://m.amedeo.com/35914777

14. NELSON B.

What poo tells us: wastewater surveillance comes of age amid covid, monkeypox,

and polio.

BMJ. 2022;378:o1869.

PubMed: http://www.amedeo.com/p2.php?id=35905991&s=cov&pm=2

Share: http://m.amedeo.com/35905991

15. REICHER S, Michie S, West R.

The UK government’s “personal responsibility” policy for covid is hypocritical

and unsustainable.

BMJ. 2022;378:o1903.

PubMed: http://www.amedeo.com/p2.php?id=35905989&s=cov&pm=2

Share: http://m.amedeo.com/35905989

16. WISE J.

Long covid: Hair loss and sexual dysfunction are among wider symptoms, study

finds.

BMJ. 2022;378:o1887.

PubMed: http://www.amedeo.com/p2.php?id=35896202&s=cov&pm=2

Share: http://m.amedeo.com/35896202

17. ZHANG H, Ding Q, Yuan J, Han F, et al.

Susceptibility to mice and potential evolutionary characteristics of porcine

deltacoronavirus.

J Med Virol. 2022 Aug 4. doi: 10.1002/jmv.28048.

PubMed: http://www.amedeo.com/p2.php?id=35927214&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35927214

18. Corrigendum.

J Med Virol. 2022 Aug 4. doi: 10.1002/jmv.28046.

PubMed: http://www.amedeo.com/p2.php?id=35924748&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35924748

19. SUNTRONWONG N, Kanokudom S, Auphimai C, Assawakosri S, et al.

Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to

omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination.

J Med Virol. 2022 Aug 4. doi: 10.1002/jmv.28044.

PubMed: http://www.amedeo.com/p2.php?id=35924475&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35924475

20. Corrigendum.

J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28043.

PubMed: http://www.amedeo.com/p2.php?id=35919972&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35919972

21. LIM CC, Leeu JJ, Mok IY, Tan HZ, et al.

Influenza Vaccine Awareness and Acceptance in Kidney Disease during the

Corononavirus Disease 2019 pandemic.

J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28039.

PubMed: http://www.amedeo.com/p2.php?id=35916250&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35916250

22. KOJIMA Y, Nakakubo S, Kamada K, Yamashita Y, et al.

Combination therapy with remdesivir and immunomodulators improves respiratory

status in COVID-19: A retrospective study.

J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28037.

PubMed: http://www.amedeo.com/p2.php?id=35916111&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35916111

23. LIANG W, Wang S, Wang H, Li X, et al.

When 3D genome technology meets viral infection, including SARS-CoV-2.

J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28040.

PubMed: http://www.amedeo.com/p2.php?id=35916043&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35916043

24. PENG P, Deng H, Li Z, Chen Y, et al.

Distinct immune responses in the early phase to natural SARS-CoV-2 infection or

vaccination.

J Med Virol. 2022 Jul 29. doi: 10.1002/jmv.28034.

PubMed: http://www.amedeo.com/p2.php?id=35906179&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35906179

25. MURPHY H, Ly H.

What are the levels of risk of humans contracting SARS-CoV-2 from pets and vice

versa?

J Med Virol. 2022 Jul 29. doi: 10.1002/jmv.28035.

PubMed: http://www.amedeo.com/p2.php?id=35906099&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35906099

26. ALEXIEV I, Giovanetti M, Cella E, Ivanov I, et al.

Initial Introduction and Spread of the SARS-CoV-2 AY.4.2.1 Delta Variant in

Bulgaria, a Genomic Insight.

J Med Virol. 2022 Jul 28. doi: 10.1002/jmv.28033.

PubMed: http://www.amedeo.com/p2.php?id=35902787&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35902787

27. ZHANG GF, Meng W, Chen L, Ding L, et al.

Neutralizing Antibodies to SARS-CoV-2 Variants of Concern Including Delta and

Omicron in Subjects Receiving mRNA-1273, BNT162b2 and Ad26.COV2.S Vaccines.

J Med Virol. 2022 Jul 28. doi: 10.1002/jmv.28032.

PubMed: http://www.amedeo.com/p2.php?id=35902378&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35902378

28. ANDERSON-DANIELS J, Gribble J, Denison M.

Proteolytic Processing of the Coronavirus Replicase Nonstructural Protein 14

Exonuclease Is Not Required for Virus Replication but Alters RNA Synthesis and

Viral Fitness.

J Virol. 2022 Aug 4:e0084122. doi: 10.1128/jvi.00841.

PubMed: http://www.amedeo.com/p2.php?id=35924922&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35924922

29. ABDELNABI R, Foo CS, Kaptein SJF, Boudewijns R, et al.

A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2

Infection.

J Virol. 2022 Aug 4:e0075822. doi: 10.1128/jvi.00758.

PubMed: http://www.amedeo.com/p2.php?id=35924921&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35924921

30. CAMPAGNOLA G, Govindarajan V, Pelletier A, Canard B, et al.

The SARS-CoV nsp12 Polymerase Active Site Is Tuned for Large-Genome Replication.

J Virol. 2022 Aug 4:e0067122. doi: 10.1128/jvi.00671.

PubMed: http://www.amedeo.com/p2.php?id=35924919&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35924919

31. ZHAN W, Tian X, Zhang X, Xing S, et al.

Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody

That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.

J Virol. 2022 Aug 4:e0048022. doi: 10.1128/jvi.00480.

PubMed: http://www.amedeo.com/p2.php?id=35924918&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35924918

32. LI Z, Fang P, Duan P, Chen J, et al.

Porcine Deltacoronavirus Infection Cleaves HDAC2 to Attenuate Its Antiviral

Activity.

J Virol. 2022 Aug 2:e0102722. doi: 10.1128/jvi.01027.

PubMed: http://www.amedeo.com/p2.php?id=35916536&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35916536

33. YUAN M, Chen X, Zhu Y, Dong X, et al.

A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2

Omicron and Other Variants of Concern.

J Virol. 2022 Aug 2:e0077522. doi: 10.1128/jvi.00775.

PubMed: http://www.amedeo.com/p2.php?id=35916510&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35916510

34. GUO H, Li A, Lin HF, Liu MQ, et al.

The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an

Evolutionary Footprint.

J Virol. 2022 Jul 19:e0095822. doi: 10.1128/jvi.00958.

PubMed: http://www.amedeo.com/p2.php?id=35852351&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35852351

35. REWERS M, Bonifacio E, Ewald D, Geno Rasmussen C, et al.

SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children

and Adolescents From Colorado, USA, and Bavaria, Germany.

JAMA. 2022 Aug 5. pii: 2795226. doi: 10.1001/jama.2022.14092.

PubMed: http://www.amedeo.com/p2.php?id=35930271&s=cov&pm=2

Share: http://m.amedeo.com/35930271

36. MADHUSOODANAN J.

Animal Reservoirs-Where the Next SARS-CoV-2 Variant Could Arise.

JAMA. 2022 Aug 3. pii: 2795140. doi: 10.1001/jama.2022.9789.

PubMed: http://www.amedeo.com/p2.php?id=35921126&s=cov&pm=2

Share: http://m.amedeo.com/35921126

37. LEVINE RL.

Addressing the Long-term Effects of COVID-19.

JAMA. 2022 Aug 3. pii: 2795139. doi: 10.1001/jama.2022.14089.

PubMed: http://www.amedeo.com/p2.php?id=35921084&s=cov&pm=2

Share: http://m.amedeo.com/35921084

38. SLOMSKI A.

Sickle Cell Trait Associated With Kidney Failure and COVID-19 Death.

JAMA. 2022;328:415.

PubMed: http://www.amedeo.com/p2.php?id=35916859&s=cov&pm=2

Share: http://m.amedeo.com/35916859

39. SLOMSKI A.

Maternal Death Rate Increased During Early COVID-19 Pandemic.

JAMA. 2022;328:415.

PubMed: http://www.amedeo.com/p2.php?id=35916856&s=cov&pm=2

Share: http://m.amedeo.com/35916856

40. GENZEN JR, Rychert J, George TI.

Integrity of SARS-CoV-2 Laboratory-Developed Tests.

JAMA. 2022;328:478.

PubMed: http://www.amedeo.com/p2.php?id=35916853&s=cov&pm=2

Share: http://m.amedeo.com/35916853

41. ADASHI EY, Cohen G.

Integrity of SARS-CoV-2 Laboratory-Developed Tests-Reply.

JAMA. 2022;328:478-479.

PubMed: http://www.amedeo.com/p2.php?id=35916850&s=cov&pm=2

Share: http://m.amedeo.com/35916850

42. BIRNIE E, Biemond JJ, Appelman B, de Bree GJ, et al.

Development of Resistance-Associated Mutations After Sotrovimab Administration in

High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.

JAMA. 2022 Aug 1. pii: 2794999. doi: 10.1001/jama.2022.13854.

PubMed: http://www.amedeo.com/p2.php?id=35913747&s=cov&pm=2

Share: http://m.amedeo.com/35913747

43. VASAN A, Foote M, Long T.

Ensuring Widespread and Equitable Access to Treatments for COVID-19.

JAMA. 2022 Jul 29. pii: 2794967. doi: 10.1001/jama.2022.13554.

PubMed: http://www.amedeo.com/p2.php?id=35904777&s=cov&pm=2

Share: http://m.amedeo.com/35904777

44. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a

randomised, controlled, open-label, platform trial and updated meta-analysis.

Lancet. 2022;400:359-368.

PubMed: http://www.amedeo.com/p2.php?id=35908569&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35908569

45. THORNTON J.

Violence against health workers rises during COVID-19.

Lancet. 2022;400:348.

PubMed: http://www.amedeo.com/p2.php?id=35908564&s=cov&pm=2

Share: http://m.amedeo.com/35908564

46. MEHTA P, Titanji BK.

Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing

mortality.

Lancet. 2022;400:338-339.

PubMed: http://www.amedeo.com/p2.php?id=35908561&s=cov&pm=2

Share: http://m.amedeo.com/35908561

47. KHUON D, Ogrin S, Engels J, Aldrich A, et al.

Notes from the Field: Increase in Pediatric Intracranial Infections During the

COVID-19 Pandemic – Eight Pediatric Hospitals, United States, March 2020-March

2022.

MMWR Morb Mortal Wkly Rep. 2022;71:1000-1001.

PubMed: http://www.amedeo.com/p2.php?id=35925822&s=cov&pm=2

Share: http://m.amedeo.com/35925822

48. TWENTYMAN E, Wallace M, Roper LE, Anderson TC, et al.

Interim Recommendation of the Advisory Committee on Immunization Practices for

Use of the Novavax COVID-19 Vaccine in Persons Aged >/=18 years – United States,

July 2022.

MMWR Morb Mortal Wkly Rep. 2022;71:988-992.

PubMed: http://www.amedeo.com/p2.php?id=35925807&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35925807

49. KOMPANIYETS L, Bull-Otterson L, Boehmer TK, Baca S, et al.

Post-COVID-19 Symptoms and Conditions Among Children and Adolescents – United

States, March 1, 2020-January 31, 2022.

MMWR Morb Mortal Wkly Rep. 2022;71:993-999.

PubMed: http://www.amedeo.com/p2.php?id=35925799&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35925799

50. RUBIN EJ, Baden LR, Morrissey S.

Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox.

N Engl J Med. 2022;387:e16.

PubMed: http://www.amedeo.com/p2.php?id=35921460&s=cov&pm=2

Share: http://m.amedeo.com/35921460

51. Mild-COVID drugs, Omicron protection and disco-ball satellite.

Nature. 2022;608:13.

PubMed: http://www.amedeo.com/p2.php?id=35922559&s=cov&pm=2

Share: http://m.amedeo.com/35922559

52. Get childhood immunizations back on track after COVID.

Nature. 2022;608:7-8.

PubMed: http://www.amedeo.com/p2.php?id=35922556&s=cov&pm=2

Share: http://m.amedeo.com/35922556

53. A first update on mapping the human genetic architecture of COVID-19.

Nature. 2022;608:E1-E10.

PubMed: http://www.amedeo.com/p2.php?id=35922517&s=cov&pm=2

Share: http://m.amedeo.com/35922517

54. CHU H, Hou Y, Yang D, Wen L, et al.

Coronaviruses exploit a host cysteine-aspartic protease for replication.

Nature. 2022 Aug 3. pii: 10.1038/s41586-022-05148.

PubMed: http://www.amedeo.com/p2.php?id=35922005&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35922005

55. SIDIK SM.

Heart disease after COVID: what the data say.

Nature. 2022;608:26-28.

PubMed: http://www.amedeo.com/p2.php?id=35918523&s=cov&pm=2

Share: http://m.amedeo.com/35918523

56. BAKER N, Maxmen A.

Coronapod: the open-science plan to unseat big Pharma and tackle vaccine

inequity.

Nature. 2022 Jul 29. pii: 10.1038/d41586-022-02094.

PubMed: http://www.amedeo.com/p2.php?id=35907979&s=cov&pm=2

Share: http://m.amedeo.com/35907979

57. SELLERGREN AB, Chen C, Nabulsi Z, Li Y, et al.

Simplified Transfer Learning for Chest Radiography Models Using Less Data.

Radiology. 2022 Jul 19:212482. doi: 10.1148/radiol.212482.

PubMed: http://www.amedeo.com/p2.php?id=35852426&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35852426

58. SHAFAATI M, Zandi M.

Monkeypox virus neurological manifestations in comparison to other

orthopoxviruses.

Travel Med Infect Dis. 2022 Aug 1:102414. doi: 10.1016/j.tmaid.2022.102414.

PubMed: http://www.amedeo.com/p2.php?id=35926767&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35926767

59. LI C, Zhu X, Zhang Y, Zhang J, et al.

COVID-19 influences both physical and mental health: Lessons from bibliometric

analysis.

Travel Med Infect Dis. 2022 Jul 30:102405. doi: 10.1016/j.tmaid.2022.102405.

PubMed: http://www.amedeo.com/p2.php?id=35917914&s=cov&pm=2

Share: http://m.amedeo.com/35917914

60. LONG QY, Zheng YL, Gao Z.

[Advances in SARS-CoV-2 diagnostic strategies during the later COVID-19 era].

Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:819-825.

PubMed: http://www.amedeo.com/p2.php?id=35927053&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35927053

#Zika Virus Research References (by AMEDEO, August 7 ’22)

1. RAASCH LE, Yamamoto K, Newman CM, Rosinski JR, et al.

Fetal loss in pregnant rhesus macaques infected with high-dose African-lineage

Zika virus.

PLoS Negl Trop Dis. 2022;16:e0010623.

PubMed: http://www.amedeo.com/p2.php?id=35926066&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35926066

2. HADDOW AD.

Why does Zika virus persist in the semen of some men but not others?

J Infect Dis. 2022 Aug 4. pii: 6655540. doi: 10.1093.

PubMed: http://www.amedeo.com/p2.php?id=35924449&s=zik&pm=2

Share: http://m.amedeo.com/35924449

3. VOGT MB, McDonald EM, Delorey M, Mead PS, et al.

Prolonged shedding of Zika virus in human semen is associated with male

reproductive tract inflammation.

J Infect Dis. 2022 Aug 4. pii: 6655539. doi: 10.1093.

PubMed: http://www.amedeo.com/p2.php?id=35924442&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35924442

4. GRANT R, Kizu J, Graham M, McCallum F, et al.

Serological evidence of possible high levels of undetected transmission of Zika

virus among Papua New Guinea military personnel, 2019.

IJID Reg. 2022;4:131-133.

PubMed: http://www.amedeo.com/p2.php?id=35923646&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35923646

5. CAO X, Liu K, Yan S, Li S, et al.

Mechanical regulation of the helicase activity of Zika virus NS3.

Biophys J. 2022 Aug 2. pii: S0006-3495(22)00603.

PubMed: http://www.amedeo.com/p2.php?id=35923103&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35923103

6. OBADIA T, Gutierrez-Bugallo G, Duong V, Nunez AI, et al.

Zika vector competence data reveals risks of outbreaks: the contribution of the

European ZIKAlliance project.

Nat Commun. 2022;13:4490.

PubMed: http://www.amedeo.com/p2.php?id=35918360&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35918360

7. SILVA LVO, Hermont AP, Magnani IQ, Martins CC, et al.

Oral alterations in children with microcephaly associated to congenital Zika

syndrome: A systematic review and meta-analyses.

Spec Care Dentist. 2022 Aug 1. doi: 10.1111/scd.12761.

PubMed: http://www.amedeo.com/p2.php?id=35912588&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35912588

8. BOLIVAR-MARIN S, Bosch I, Narvaez CF.

Combination of the Focus-Forming Assay and Digital Automated Imaging Analysis for

the Detection of Dengue and Zika Viral Loads in Cultures and Acute Disease.

J Trop Med. 2022;2022:2177183.

PubMed: http://www.amedeo.com/p2.php?id=35911823&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35911823

9. MARIN-LOPEZ A, Wang Y, Jiang J, Ledizet M, et al.

Erratum to “AgBR1 and NeSt1 antisera protect mice from Aedes aegypti-borne Zika

infection” [Vaccine 39(12) (2021) 1675-1679].

Vaccine. 2022 Jul 27. pii: S0264-410X(22)00608.

PubMed: http://www.amedeo.com/p2.php?id=35907678&s=zik&pm=2

Share: http://m.amedeo.com/35907678

10. DELANEY A, Olson SM, Roth NM, Cragan JD, et al.

Prevalence of individual brain and eye defects potentially related to Zika virus

in pregnancy in 22 U.S. states and territories, January 2016 to June 2017.

Birth Defects Res. 2022 Jul 30. doi: 10.1002/bdr2.2067.

PubMed: http://www.amedeo.com/p2.php?id=35906998&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35906998

11. MULLER WIM, Gama GL, Borges MCD, Bastos BMAM, et al.

Effect of neurodevelopmental treatment in children with congenital Zika syndrome:

A pilot study.

J Paediatr Child Health. 2022 Jul 30. doi: 10.1111/jpc.16139.

PubMed: http://www.amedeo.com/p2.php?id=35906858&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35906858

12. CHAPAGAIN S, Pal Singh P, Le K, Safronetz D, et al.

Japanese encephalitis virus persists in the human reproductive epithelium and

porcine reproductive tissues.

PLoS Negl Trop Dis. 2022;16:e0010656.

PubMed: http://www.amedeo.com/p2.php?id=35905074&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35905074

13. LIU J, Mao Y, Li Q, Qiu Z, et al.

Efficient Gene Transfer to Kidney Using a Lentiviral Vector Pseudotyped with Zika

Virus Envelope Glycoprotein.

Hum Gene Ther. 2022 Jul 29. doi: 10.1089/hum.2022.

PubMed: http://www.amedeo.com/p2.php?id=35904396&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35904396

14. TREGUIER Y, Cochard J, Burlaud-Gaillard J, Lemoine R, et al.

The envelope protein of Zika virus interacts with apolipoprotein E early in the

infectious cycle and this interaction is conserved on the secreted viral

particles.

Virol J. 2022;19:124.

PubMed: http://www.amedeo.com/p2.php?id=35902969&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35902969

15. DA COSTA GV, Neto MFA, Da Silva AKP, De Sa EMF, et al.

Identification of Potential Insect Growth Inhibitor against Aedes aegypti: A

Bioinformatics Approach.

Int J Mol Sci. 2022;23.

PubMed: http://www.amedeo.com/p2.php?id=35897792&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35897792

16. YANG C, Wang F, Huang D, Ma H, et al.

Vector competence and immune response of Aedes aegypti for Ebinur Lake virus, a

newly classified mosquito-borne orthobunyavirus.

PLoS Negl Trop Dis. 2022;16:e0010642.

PubMed: http://www.amedeo.com/p2.php?id=35849620&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35849620

17. ROCHMAN ND, Wolf YI, Koonin EV.

Molecular adaptations during viral epidemics.

EMBO Rep. 2022;23:e55393.

PubMed: http://www.amedeo.com/p2.php?id=35848484&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35848484

18. MEIDANINIKJEH S, Sabouni N, Taheri M, Borjkhani M, et al.

SARS-CoV-2 and Guillain-Barre Syndrome: Lessons from Viral Infections.

Viral Immunol. 2022;35:404-417.

PubMed: http://www.amedeo.com/p2.php?id=35766944&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35766944

19. BARRERA R.

New tools for Aedes control: mass trapping.

Curr Opin Insect Sci. 2022;52:100942.

PubMed: http://www.amedeo.com/p2.php?id=35667560&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35667560

#Influenza and #COVID19 Research References (by AMEDEO, August 6 ’22)

1. HORWITZ RI, Conroy AH, Cullen MR, Colella K, et al.

Long COVID and Medicine’s Two Cultures.

Am J Med. 2022;135:945-949.

PubMed: http://www.amedeo.com/p2.php?id=35417745&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35417745

2. FRANCIS Z, Book G, Litvin C, Kalivas B, et al.

The COVID-19 Pandemic and Zinc-Induced Copper Deficiency: An Important Link.

Am J Med. 2022;135:e290-e291.

PubMed: http://www.amedeo.com/p2.php?id=35367442&s=flu&pm=2

Share: http://m.amedeo.com/35367442

3. WORMSER GP, Flatley CA, Flatley EM, White PA, et al.

Lack of Convincing Evidence That the Widely Used COVID-19 Vaccines Will Produce

Herd Immunity.

Am J Med. 2022;135:e231-e233.

PubMed: http://www.amedeo.com/p2.php?id=35139324&s=flu&pm=2

Share: http://m.amedeo.com/35139324

4. FOX J, Meisenberg B.

The 3-Fold Harms of Compassion Fatigue During COVID-19 Surges.

Am J Med. 2022;135:e234-e235.

PubMed: http://www.amedeo.com/p2.php?id=35131309&s=flu&pm=2

Share: http://m.amedeo.com/35131309

5. KOMENO T, Furuta Y, Nakajima N, Tani H, et al.

Analysis of the responsible site for favipiravir resistance in RNA-dependent RNA

polymerase of influenza virus A/PR/8/34 (H1N1) using site-directed mutagenesis.

Antiviral Res. 2022 Aug 2:105387. doi: 10.1016/j.antiviral.2022.105387.

PubMed: http://www.amedeo.com/p2.php?id=35931138&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35931138

6. YANG F, Zhang X, Liu F, Yao H, et al.

Rapid emergence of a PB2 D701N substitution during adaptation of an H9N2 avian

influenza virus in mice.

Arch Virol. 2022 Aug 3. pii: 10.1007/s00705-022-05536.

PubMed: http://www.amedeo.com/p2.php?id=35920981&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35920981

7. WARD IL, Bermingham C, Ayoubkhani D, Gethings OJ, et al.

Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with

delta (B.1.617.2): retrospective cohort study.

BMJ. 2022;378:e070695.

PubMed: http://www.amedeo.com/p2.php?id=35918098&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35918098

8. LORENZO-REDONDO R, Ozer EA, Hultquist JF.

Covid-19: is omicron less lethal than delta?

BMJ. 2022;378:o1806.

PubMed: http://www.amedeo.com/p2.php?id=35918084&s=flu&pm=2

Share: http://m.amedeo.com/35918084

9. DYER O.

Covid-19: Ontario hospitals close wards as nursing shortage bites.

BMJ. 2022;378:o1917.

PubMed: http://www.amedeo.com/p2.php?id=35914798&s=flu&pm=2

Share: http://m.amedeo.com/35914798

10. HERETH B, Tubig P, Sorrels A, Muldoon A, et al.

Long covid and disability: a brave new world.

BMJ. 2022;378:e069868.

PubMed: http://www.amedeo.com/p2.php?id=35914783&s=flu&pm=2

Share: http://m.amedeo.com/35914783

11. GRIFFIN S.

Covid-19: Staff absences in July surged amid ongoing pressure on hospitals.

BMJ. 2022;378:o1909.

PubMed: http://www.amedeo.com/p2.php?id=35914777&s=flu&pm=2

Share: http://m.amedeo.com/35914777

12. NELSON B.

What poo tells us: wastewater surveillance comes of age amid covid, monkeypox,

and polio.

BMJ. 2022;378:o1869.

PubMed: http://www.amedeo.com/p2.php?id=35905991&s=flu&pm=2

Share: http://m.amedeo.com/35905991

13. REICHER S, Michie S, West R.

The UK government’s “personal responsibility” policy for covid is hypocritical

and unsustainable.

BMJ. 2022;378:o1903.

PubMed: http://www.amedeo.com/p2.php?id=35905989&s=flu&pm=2

Share: http://m.amedeo.com/35905989

14. SAXENA S, Skirrow H, Wighton K.

Vaccinating children aged under 5 years against covid-19.

BMJ. 2022;378:o1863.

PubMed: http://www.amedeo.com/p2.php?id=35902095&s=flu&pm=2

Share: http://m.amedeo.com/35902095

15. WISE J.

Long covid: Hair loss and sexual dysfunction are among wider symptoms, study

finds.

BMJ. 2022;378:o1887.

PubMed: http://www.amedeo.com/p2.php?id=35896202&s=flu&pm=2

Share: http://m.amedeo.com/35896202

16. KYE WEN TAN N, Jing-Wen C, Tan, Kye Jyn Tan B, et al.

The burden of prolonged smell and taste loss in covid-19.

BMJ. 2022;378:o1895.

PubMed: http://www.amedeo.com/p2.php?id=35896196&s=flu&pm=2

Share: http://m.amedeo.com/35896196

17. TAN BKJ, Han R, Zhao JJ, Tan NKW, et al.

Prognosis and persistence of smell and taste dysfunction in patients with

covid-19: meta-analysis with parametric cure modelling of recovery curves.

BMJ. 2022;378:e069503.

PubMed: http://www.amedeo.com/p2.php?id=35896188&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35896188

18. DYER C.

Covid-19: “Impossible” to be confident that government awarded Randox contracts

properly, say MPs.

BMJ. 2022;378:o1893.

PubMed: http://www.amedeo.com/p2.php?id=35896187&s=flu&pm=2

Share: http://m.amedeo.com/35896187

19. DAVIES MW.

Learning from complaints during covid-19: discuss risks and benefits before

hospital treatment.

BMJ. 2022;378:o1858.

PubMed: http://www.amedeo.com/p2.php?id=35896182&s=flu&pm=2

Share: http://m.amedeo.com/35896182

20. LOSS J, Wurm J, Varnaccia G, Schienkiewitz A, et al.

Transmission of SARS-CoV-2 among children and staff in German daycare centres.

Epidemiol Infect. 2022;150:e141.

PubMed: http://www.amedeo.com/p2.php?id=35912971&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35912971

21. LI R, Li Q, Liu Y, Shen M, et al.

Modelling the impact of universal influenza vaccines on seasonal influenza with

different subtypes.

Epidemiol Infect. 2021;149:e253.

PubMed: http://www.amedeo.com/p2.php?id=35903926&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35903926

22. NIELSEN RT, Dalby T, Emborg HD, Larsen AR, et al.

COVID-19 preventive measures coincided with a marked decline in other infectious

diseases in Denmark, spring 2020.

Epidemiol Infect. 2022;150:e138.

PubMed: http://www.amedeo.com/p2.php?id=35899864&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35899864

23. AL-SHEHARI WA, Yin YA, Wang X, Wang Y, et al.

Prevalence and surveillance of tuberculosis in Yemen from 2006 to 2018.

Epidemiol Infect. 2022;150:e146.

PubMed: http://www.amedeo.com/p2.php?id=35856270&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35856270

24. SMALLMAN-RAYNOR MR, Cliff AD.

Spatial growth rate of emerging SARS-CoV-2 lineages in England, September

2020-December 2021.

Epidemiol Infect. 2022;150:e145.

PubMed: http://www.amedeo.com/p2.php?id=35855577&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35855577

25. SILVA MJA, Rodrigues YC, Lima KVB, Lima LNGC, et al.

Innate immunity to SARS-CoV-2 infection: a review.

Epidemiol Infect. 2022;150:e142.

PubMed: http://www.amedeo.com/p2.php?id=35843719&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35843719

26. IMPOUMA B, Mboussou F, Farham B, Makubalo L, et al.

COVID-19 vaccination rollout in the World Health Organization African region:

status at end June 2022 and way forward.

Epidemiol Infect. 2022;150:e143.

PubMed: http://www.amedeo.com/p2.php?id=35818789&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35818789

27. JANNUZZI P, Panza GA.

Author response to: Letter to Editor in Response to the association between

contact with children and the clinical course of COVID-19.

Epidemiol Infect. 2022;150:e139.

PubMed: http://www.amedeo.com/p2.php?id=35811426&s=flu&pm=2

Share: http://m.amedeo.com/35811426

28. AUSTHOF E, Bell ML, Riddle MS, Catalfamo C, et al.

Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome

following SARS-CoV-2 infection: results from the Arizona CoVHORT.

Epidemiol Infect. 2022 Jul 8:1-22. doi: 10.1017/S0950268822001200.

PubMed: http://www.amedeo.com/p2.php?id=35801302&s=flu&pm=2

Share: http://m.amedeo.com/35801302

29. SOYEMI E, Soyemi K.

Response to the association between contact with children and the clinical course

of COVID-19.

Epidemiol Infect. 2022;150:e140.

PubMed: http://www.amedeo.com/p2.php?id=35794748&s=flu&pm=2

Share: http://m.amedeo.com/35794748

30. CIPOLLA EM, Yue M, Nickolich KL, Huckestein BR, et al.

Heterotypic Influenza Infections Mitigate Susceptibility to Secondary Bacterial

Infection.

J Immunol. 2022 Aug 1. pii: jimmunol.2200261. doi: 10.4049/jimmunol.2200261.

PubMed: http://www.amedeo.com/p2.php?id=35914833&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35914833

31. RICHARDS A, Muddassir M, Sampson F, MacLachlan L, et al.

Evaluation of pre-hospital COVID-19 rapid antigen tests by paramedics and their

use in a direct admission pathway: Pre-Hospital COVID-19 rapid antigen tests.

J Infect. 2022 Jun 18. pii: S0163-4453(22)00371.

PubMed: http://www.amedeo.com/p2.php?id=35728641&s=flu&pm=2

Share: http://m.amedeo.com/35728641

32. PENG H, Wu X, Xiong S, Li C, et al.

Gout and susceptibility and severity of COVID-19: a bidirectional Mendelian

randomization analysis.

J Infect. 2022 Jun 17. pii: S0163-4453(22)00366.

PubMed: http://www.amedeo.com/p2.php?id=35724757&s=flu&pm=2

Share: http://m.amedeo.com/35724757

33. HATCHER J, Gil E, Storey N, Brown JR, et al.

Reactivation/relapse of SARS-CoV-2 in a child following haematopoietic stem cell

transplantation, confirmed by whole genome sequencing, following apparent viral

clearance.

J Infect. 2022 Jun 17. pii: S0163-4453(22)00367.

PubMed: http://www.amedeo.com/p2.php?id=35724755&s=flu&pm=2

Share: http://m.amedeo.com/35724755

34. COCHINO AV, Farkas OM, Ioan A.

Pediatric Patients with Immune-Mediated Diseases on Immunosuppressants Have Low

Risk of Severe COVID-19 and No Increase in Flare Rate after SARS CoV-2 Exposure.

J Infect. 2022 Jun 17. pii: S0163-4453(22)00365.

PubMed: http://www.amedeo.com/p2.php?id=35724754&s=flu&pm=2

Share: http://m.amedeo.com/35724754

35. LAZARUS R, Taucher C, Brown C, Corbic I, et al.

Safety and immunogenicity of the inactivated whole-virus adjuvanted vaccine

VLA2001: a randomized, dose escalation, double-blind phase 1/2 clinical trial in

healthy adults.

J Infect. 2022 Jun 16. pii: S0163-4453(22)00361.

PubMed: http://www.amedeo.com/p2.php?id=35718205&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35718205

36. WORSLEY CM, van der Mescht MA, Hoffman D, Meyer PWA, et al.

Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to

health care workers.

J Infect. 2022 Jun 12. pii: S0163-4453(22)00360.

PubMed: http://www.amedeo.com/p2.php?id=35705136&s=flu&pm=2

Share: http://m.amedeo.com/35705136

37. KANG SW, Kim JY, Park H, Lim SY, et al.

Comparison of outward transmission potential between vaccinated and partially

vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant

infection.

J Infect. 2022 Jun 12. pii: S0163-4453(22)00355.

PubMed: http://www.amedeo.com/p2.php?id=35705135&s=flu&pm=2

Share: http://m.amedeo.com/35705135

38. GABBI C, Renieri A, Strandvik B.

Geographical distribution of cystic fibrosis carriers as population genetic

determinant of COVID-19 spread and fatality in 37 countries.

J Infect. 2022 Jun 11. pii: S0163-4453(22)00359.

PubMed: http://www.amedeo.com/p2.php?id=35700866&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35700866

39. SANG L, Cheng B, Yu Y, Xi Y, et al.

The efficacy and safety of IBI314 on Delta and Omicron variant of SARS-CoV-2:

first-in-human evidence.

J Infect. 2022 Jun 9. pii: S0163-4453(22)00354.

PubMed: http://www.amedeo.com/p2.php?id=35691517&s=flu&pm=2

Share: http://m.amedeo.com/35691517

40. XU QY, Li QL, Jia ZJ, Wu MJ, et al.

Is the fourth COVID-19 vaccine dose urgently needed? Revelation from a

prospective cohort study.

J Infect. 2022 Jun 9. pii: S0163-4453(22)00356.

PubMed: http://www.amedeo.com/p2.php?id=35691516&s=flu&pm=2

Share: http://m.amedeo.com/35691516

41. LV P, Hu B, Hua R, Zhang J, et al.

A novelly designed protein antagonist confers potent neutralization against

SARS-COV-2 variants of concern.

J Infect. 2022 Jun 3. pii: S0163-4453(22)00350.

PubMed: http://www.amedeo.com/p2.php?id=35667483&s=flu&pm=2

Share: http://m.amedeo.com/35667483

42. WANG B, Fu J, Lu A, Yang J, et al.

Suitability assessment of CD24 targeted-therapy in the cancer patients with

COVID-19: Preliminary results from pan-cancer.

J Infect. 2022 May 31. pii: S0163-4453(22)00337.

PubMed: http://www.amedeo.com/p2.php?id=35659914&s=flu&pm=2

Share: http://m.amedeo.com/35659914

43. GUO Z, Zhao S, Ryu S, Mok CKP, et al.

Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1

variant in South Korea.

J Infect. 2022 Jun 1. pii: S0163-4453(22)00344.

PubMed: http://www.amedeo.com/p2.php?id=35659549&s=flu&pm=2

Share: http://m.amedeo.com/35659549

44. STANKUNAS M, Dziugys A, Skarbalius G, Misiulis E, et al.

EVALUATING THE POTENTIAL IMPACT OF COVID-19 PASSPORTS IN LITHUANIA.

J Infect. 2022 Jun 1. pii: S0163-4453(22)00340.

PubMed: http://www.amedeo.com/p2.php?id=35659544&s=flu&pm=2

Share: http://m.amedeo.com/35659544

45. LI Y, Guo Y, Duan Y.

Changes in Streptococcus pneumoniae infection in children before and after the

COVID-19 pandemic in Zhengzhou, China.

J Infect. 2022 Jun 1. pii: S0163-4453(22)00348.

PubMed: http://www.amedeo.com/p2.php?id=35659542&s=flu&pm=2

Share: http://m.amedeo.com/35659542

46. GIANNONE D, Vecchione MB, Czernikier A, Polo ML, et al.

SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent

individuals with HIV.

J Infect. 2022 May 27. pii: S0163-4453(22)00315.

PubMed: http://www.amedeo.com/p2.php?id=35636532&s=flu&pm=2

Share: http://m.amedeo.com/35636532

47. ZOU P, Li G, Ge X, Wang J, et al.

Lymphocyte subset changes in neonates with respiratory syncytial virus pneumonia.

J Infect. 2022;85:334-363.

PubMed: http://www.amedeo.com/p2.php?id=35623452&s=flu&pm=2

Share: http://m.amedeo.com/35623452

48. KAMALI Z, Vonk JM, Thio CHL, Vaez A, et al.

A Mendelian randomization cytokine screen reveals IL-13 as causal factor in risk

of severe COVID-19.

J Infect. 2022 May 23. pii: S0163-4453(22)00313.

PubMed: http://www.amedeo.com/p2.php?id=35618154&s=flu&pm=2

Share: http://m.amedeo.com/35618154

49. CHAN M, Tiwary M, Wu HL, Tailor N, et al.

Pandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or

Cynomolgus Macaques.

J Virol. 2022 Aug 4:e0072822. doi: 10.1128/jvi.00728.

PubMed: http://www.amedeo.com/p2.php?id=35924920&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35924920

50. ABBADI N, Nagashima K, Pena-Briseno A, Ross TM, et al.

Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza

Vaccine Candidates by Human Antibodies.

J Virol. 2022 Aug 2:e0089622. doi: 10.1128/jvi.00896.

PubMed: http://www.amedeo.com/p2.php?id=35916534&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35916534

51. SCHWAB LSU, Londrigan SL, Brooks AG, Hurt AC, et al.

Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of

Influenza A Virus in Lungs after RIG-I Agonist Treatment of Ferrets.

J Virol. 2022 Aug 2:e0055922. doi: 10.1128/jvi.00559.

PubMed: http://www.amedeo.com/p2.php?id=35916513&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35916513

52. XU C, Zhang N, Yang Y, Liang W, et al.

Immune Escape Adaptive Mutations in Hemagglutinin Are Responsible for the

Antigenic Drift of Eurasian Avian-Like H1N1 Swine Influenza Viruses.

J Virol. 2022 Aug 2:e0097122. doi: 10.1128/jvi.00971.

PubMed: http://www.amedeo.com/p2.php?id=35916512&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35916512

53. VAN OOSTEN L, Yan K, Rawle DJ, Le TT, et al.

An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2

Mice.

J Virol. 2022 Jun 29:e0084422. doi: 10.1128/jvi.00844.

PubMed: http://www.amedeo.com/p2.php?id=35766489&s=flu&pm=2

Share: http://m.amedeo.com/35766489

54. JIANG C, Li L, Xue M, Zhao L, et al.

Long-Term Expanding Porcine Airway Organoids Provide Insights into the

Pathogenesis and Innate Immunity of Porcine Respiratory Coronavirus Infection.

J Virol. 2022 Jun 28:e0073822. doi: 10.1128/jvi.00738.

PubMed: http://www.amedeo.com/p2.php?id=35762755&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35762755

55. DIEBOLD O, Gonzalez V, Venditti L, Sharp C, et al.

Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses

Expressing SARS-CoV-2 Spike Epitopes.

J Virol. 2022 Jun 27:e0048822. doi: 10.1128/jvi.00488.

PubMed: http://www.amedeo.com/p2.php?id=35758692&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35758692

56. AZEEM S, Guo B, Sun D, Killian ML, et al.

Evaluation of PCR-Based Hemagglutinin Subtyping as a Tool to aid in Surveillance

of Avian Influenza viruses in Migratory Wild Birds.

J Virol Methods. 2022 Aug 2:114594. doi: 10.1016/j.jviromet.2022.114594.

PubMed: http://www.amedeo.com/p2.php?id=35931229&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35931229

57. SLOMSKI A.

Sickle Cell Trait Associated With Kidney Failure and COVID-19 Death.

JAMA. 2022;328:415.

PubMed: http://www.amedeo.com/p2.php?id=35916859&s=flu&pm=2

Share: http://m.amedeo.com/35916859

58. SLOMSKI A.

Maternal Death Rate Increased During Early COVID-19 Pandemic.

JAMA. 2022;328:415.

PubMed: http://www.amedeo.com/p2.php?id=35916856&s=flu&pm=2

Share: http://m.amedeo.com/35916856

59. GENZEN JR, Rychert J, George TI.

Integrity of SARS-CoV-2 Laboratory-Developed Tests.

JAMA. 2022;328:478.

PubMed: http://www.amedeo.com/p2.php?id=35916853&s=flu&pm=2

Share: http://m.amedeo.com/35916853

60. ADASHI EY, Cohen G.

Integrity of SARS-CoV-2 Laboratory-Developed Tests-Reply.

JAMA. 2022;328:478-479.

PubMed: http://www.amedeo.com/p2.php?id=35916850&s=flu&pm=2

Share: http://m.amedeo.com/35916850

61. RUBIN R.

COVID-19 Boosters This Fall to Include Omicron Antigen, but Questions Remain

About Its Value.

JAMA. 2022 Jul 8. pii: 2794259. doi: 10.1001/jama.2022.11252.

PubMed: http://www.amedeo.com/p2.php?id=35802386&s=flu&pm=2

Share: http://m.amedeo.com/35802386

62. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a

randomised, controlled, open-label, platform trial and updated meta-analysis.

Lancet. 2022;400:359-368.

PubMed: http://www.amedeo.com/p2.php?id=35908569&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35908569

63. THORNTON J.

Violence against health workers rises during COVID-19.

Lancet. 2022;400:348.

PubMed: http://www.amedeo.com/p2.php?id=35908564&s=flu&pm=2

Share: http://m.amedeo.com/35908564

64. MEHTA P, Titanji BK.

Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing

mortality.

Lancet. 2022;400:338-339.

PubMed: http://www.amedeo.com/p2.php?id=35908561&s=flu&pm=2

Share: http://m.amedeo.com/35908561

65. DURRHEIM DN.

Perilous two-tier COVID-19 global vaccine roll-out.

Lancet. 2022 Jul 11. pii: S0140-6736(22)01284.

PubMed: http://www.amedeo.com/p2.php?id=35835125&s=flu&pm=2

Share: http://m.amedeo.com/35835125

66. DALZIEL SR, Haskell L, O’Brien S, Borland ML, et al.

Bronchiolitis.

Lancet. 2022;400:392-406.

PubMed: http://www.amedeo.com/p2.php?id=35785792&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35785792

67. HAUSE AM, Baggs J, Marquez P, Abara WE, et al.

Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged

>/=50 Years – United States, March 29, 2022-July 10, 2022.

MMWR Morb Mortal Wkly Rep. 2022;71:971-976.

PubMed: http://www.amedeo.com/p2.php?id=35900925&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35900925

68. RUBIN EJ, Baden LR, Morrissey S.

Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox.

N Engl J Med. 2022;387:e16.

PubMed: http://www.amedeo.com/p2.php?id=35921460&s=flu&pm=2

Share: http://m.amedeo.com/35921460

69. HAMMOND J, Bao W, Simon-Campos A.

Nirmatrelvir for Nonhospitalized Adults with Covid-19. Reply.

N Engl J Med. 2022;387.

PubMed: http://www.amedeo.com/p2.php?id=35857649&s=flu&pm=2

Share: http://m.amedeo.com/35857649

70. MORRIS AM, Lee TC.

Nirmatrelvir for Nonhospitalized Adults with Covid-19.

N Engl J Med. 2022;387.

PubMed: http://www.amedeo.com/p2.php?id=35857648&s=flu&pm=2

Share: http://m.amedeo.com/35857648

71. CHEN BS, Hung CH, Wei JC.

Nirmatrelvir for Nonhospitalized Adults with Covid-19.

N Engl J Med. 2022;387.

PubMed: http://www.amedeo.com/p2.php?id=35857647&s=flu&pm=2

Share: http://m.amedeo.com/35857647

72. KRYMOVA E, Bejar B, Thanou D, Sun T, et al.

Trend estimation and short-term forecasting of COVID-19 cases and deaths

worldwide.

Proc Natl Acad Sci U S A. 2022;119:e2112656119.

PubMed: http://www.amedeo.com/p2.php?id=35921436&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35921436

73. BANKER M, Miller M, Voichek G, Goor D, et al.

Prosocial nudges and visual indicators increase social distancing, but

authoritative nudges do not.

Proc Natl Acad Sci U S A. 2022;119:e2116156119.

PubMed: http://www.amedeo.com/p2.php?id=35917368&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35917368

74. GAMBETTA D, Morisi D.

COVID-19 infection induces higher trust in strangers.

Proc Natl Acad Sci U S A. 2022;119:e2116818119.

PubMed: http://www.amedeo.com/p2.php?id=35917349&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35917349

75. CHANDRA S.

Data analysis of viral complementary DNA/RNA sequences for low-frequency

intrahost-single nucleotide variants in COVID-19.

Proc Natl Acad Sci U S A. 2022;119:e2205269119.

PubMed: http://www.amedeo.com/p2.php?id=35914186&s=flu&pm=2

Share: http://m.amedeo.com/35914186

76. BASHOR L, Gagne RB, Bosco-Lauth A, Bowen RA, et al.

Reply to Chandra: Severe Acute Respiratory Syndrome-Coronavirus-2 variant

analysis reveals within-host selection of intra-host single nucleotide variants.

Proc Natl Acad Sci U S A. 2022;119:e2206919119.

PubMed: http://www.amedeo.com/p2.php?id=35914184&s=flu&pm=2

Share: http://m.amedeo.com/35914184

77. LUO G, Zhang J, Lin L, Mignot EJ, et al.

Characterization of T cell receptors reactive to HCRTNH2, pHA273-287, and NP17-31

in control and narcolepsy patients.

Proc Natl Acad Sci U S A. 2022;119:e2205797119.

PubMed: http://www.amedeo.com/p2.php?id=35914171&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35914171

78. MELIN JL, Correll SJ.

Preventing soft skill decay among early-career women in STEM during COVID-19:

Evidence from a longitudinal intervention.

Proc Natl Acad Sci U S A. 2022;119:e2123105119.

PubMed: http://www.amedeo.com/p2.php?id=35914160&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35914160

79. ZHANG Y, Lu M, Mahesh KC, Kim E, et al.

A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine

candidate expressing a six-proline stabilized prefusion spike.

Proc Natl Acad Sci U S A. 2022;119:e2201616119.

PubMed: http://www.amedeo.com/p2.php?id=35895717&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35895717

80. IWAMURA C, Hirahara K, Kiuchi M, Ikehara S, et al.

Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced

lung exudative vasculitis and predicts COVID-19 severity.

Proc Natl Acad Sci U S A. 2022;119:e2203437119.

PubMed: http://www.amedeo.com/p2.php?id=35895716&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35895716

81. SOLOMON MD, Escobar GJ, Lu Y, Schlessinger D, et al.

Risk of severe COVID-19 infection among adults with prior exposure to children.

Proc Natl Acad Sci U S A. 2022;119:e2204141119.

PubMed: http://www.amedeo.com/p2.php?id=35895714&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35895714

82. MIMURA W, Ishiguro C, Fukuda H.

Influenza vaccine effectiveness against hospitalization during the 2018/2019

season among older persons aged>/=75years in Japan: The LIFE-VENUS Study.

Vaccine. 2022 Jul 15. pii: S0264-410X(22)00852.

PubMed: http://www.amedeo.com/p2.php?id=35851488&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35851488

83. WANG T, Wei F, Jiang Z, Song J, et al.

Influenza virus NS1 interacts with 14-3-3epsilon to antagonize the production of

RIG-I-mediated type I interferons.

Virology. 2022;574:47-56.

PubMed: http://www.amedeo.com/p2.php?id=35926243&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35926243

84. OH J, Subbiah J, Kim KH, Park BR, et al.

Impact of hemagglutination activity and M2e immunity on conferring protection

against influenza viruses.

Virology. 2022;574:37-46.

PubMed: http://www.amedeo.com/p2.php?id=35914365&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35914365

85. SHAPIRO JP, Anspacher M, Madrigal V, Lantos JD, et al.

Disposition Decisions in Cases of Medical Complexity and Health Inequity.

Pediatrics. 2022;150.

PubMed: http://www.amedeo.com/p2.php?id=35909152&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35909152

86. DROGALIS-KIM D, Kramer C, Duran S.

Ongoing Dizziness Following Acute COVID-19 Infection: A Single Center Pediatric

Case Series.

Pediatrics. 2022;150.

PubMed: http://www.amedeo.com/p2.php?id=35642018&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35642018

87. KARATZIOS C, Scuccimarri R, Chedeville G, Basfar W, et al.

Multisystem Inflammatory Syndrome Following SARS-CoV-2 Vaccination in Two

Children.

Pediatrics. 2022 May 26. pii: 188099. doi: 10.1542/peds.2021-055956.

PubMed: http://www.amedeo.com/p2.php?id=35614536&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35614536

88. BARTON HJ, Werner NE, Morgen M, DeMuri GP, et al.

Task Analysis of In-Home SARS-CoV-2 Rapid Antigen Testing by Families.

Pediatrics. 2022;150.

PubMed: http://www.amedeo.com/p2.php?id=35610754&s=flu&pm=2

Share: http://m.amedeo.com/35610754

89. NYGAARD U, Holm M, Dungu KHS, Matthesen AT, et al.

Risk of Myopericarditis After COVID-19 Vaccination in Danish Children Aged 5-11

Years.

Pediatrics. 2022 May 19. pii: 188025. doi: 10.1542/peds.2022-057508.

PubMed: http://www.amedeo.com/p2.php?id=35585684&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35585684

90. HAUSE AM, Shay DK, Klein NP, Abara WE, et al.

Safety of COVID-19 Vaccination in US Children Ages 5-11 Years.

Pediatrics. 2022 May 18. pii: 188023. doi: 10.1542/peds.2022-057313.

PubMed: http://www.amedeo.com/p2.php?id=35581698&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35581698

91. OLIVER SE, Wallace M, Link-Gelles R.

COVID-19 Vaccines: Safe and Effective in Children Ages 5-11 Years.

Pediatrics. 2022 May 18. pii: 188024. doi: 10.1542/peds.2022-057314.

PubMed: http://www.amedeo.com/p2.php?id=35581697&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35581697

92. BRUNS N, Willemsen L, Stang A, Kowall B, et al.

Pediatric Intensive Care Unit Admissions After Adolescent Suicide Attempts During

the Pandemic.

Pediatrics. 2022 May 10. pii: 187005. doi: 10.1542/peds.2021-055973.

PubMed: http://www.amedeo.com/p2.php?id=35534988&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35534988

93. WOODRUFF RC, Campbell AP, Taylor CA, Chai SJ, et al.

Risk Factors for Severe COVID-19 in Children.

Pediatrics. 2022;149.

PubMed: http://www.amedeo.com/p2.php?id=34935038&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/34935038

#Monkeypox Virus References (August 2 ’22)

Monkeypox infection among men who have sex with men: PCR testing on seminal fluids. Raccagni AR, Candela C, DavideMileto, Canetti D, Bruzzesi E, Rizzo A, Castagna A, Nozza S. J Infect. 2022 Jul 29:S0163-4453(22)00449-2. doi: 10.1016/j.jinf.2022.07.022. Online ahead of print. PMID: 35914609 No abstract available.
Evolutionary implications of human transmission of monkeypox: the importance of sequencing multiple lesions. Ulaeto DO, Dunning J, Carroll MW. Lancet Microbe. 2022 Jul 29:S2666-5247(22)00194-X. doi: 10.1016/S2666-5247(22)00194-X. Online ahead of print. PMID: 35914540 No abstract available.
Ophthalmic manifestation of monkeypox infection. Benatti SV, Venturelli S, Comi N, Borghi F, Paolucci S, Baldanti F. Lancet Infect Dis. 2022 Jul 29:S1473-3099(22)00504-7. doi: 10.1016/S1473-3099(22)00504-7. Online ahead of print. PMID: 35914539 No abstract available.
Monkeypox present with genital ulcers-challenging clinical problem. Bociąga-Jasik M, Raczyńska A, Lara M, Kalinowska-Nowak A, Garlicki A. Pol Arch Intern Med. 2022 Jul 29:16304. doi: 10.20452/pamw.16304. Online ahead of print. PMID: 35912913 No abstract available.
Monkeypox in Germany-Initial Clinical Observations. Hoffmann C, Jessen H, Boesecke C. Dtsch Arztebl Int. 2022 Aug 12;(Forthcoming):arztebl.m2022.0287. doi: 10.3238/arztebl.m2022.0287. Online ahead of print. PMID: 35912445
Why Should RNA Viruses Have All the Fun – Monkeypox, a Close Relative of Smallpox and a DNA Virus. Thakur S, Kelkar D, Garg S, Raina SK, Lateef F, Gilada I, Kumar V, Bhoi S, Galwankar S, Chauhan V. J Glob Infect Dis. 2022 Jun 29;14(2):47-49. doi: 10.4103/jgid.jgid_104_22. eCollection 2022 Apr-Jun. PMID: 35910829 Free PMC article. No abstract available.
Monkeypox Outbreaks in 2022: Battling Another “Pandemic” of Misinformation. Ennab F, Nawaz FA, Narain K, Nchasi G, Essar MY, Head MG, Singla RK, Atanasov AG, Shen B. Int J Public Health. 2022 Jul 14;67:1605149. doi: 10.3389/ijph.2022.1605149. eCollection 2022. PMID: 35910429 Free PMC article. No abstract available.
Monkeypox – a description of the clinical progression of skin lesions: a case report from Colorado, USA. Ortiz-Martínez Y, Rodríguez-Morales AJ, Franco-Paredes C, Chastain DB, Gharamti AA, Vargas Barahona L, Henao-Martínez AF. Ther Adv Infect Dis. 2022 Jul 27;9:20499361221117726. doi: 10.1177/20499361221117726. eCollection 2022 Jan-Dec. PMID: 35910397 Free PMC article.
First confirmed case of monkeypox in Adamawa State, Nigeria: a clinico-epidemiological case report. Pembi E, Awang S, Salaudeen SO, Agaba IA, Omoleke S. Pan Afr Med J. 2022 May 16;42:38. doi: 10.11604/pamj.2022.42.38.34715. eCollection 2022. PMID: 35910060 Free PMC article.

#Coronavirus Disease Research References (by AMEDEO, July 31 ’22)

1. MANG S, Wengenmayer T, Danziger G, Muellenbach RM, et al.

Extracorporeal Membrane Oxygenation Transport for Severe COVID-19 – Why We Can

and Should!

Am J Respir Crit Care Med. 2022 Jul 26. doi: 10.1164/rccm.202207-1305.

PubMed: http://www.amedeo.com/p2.php?id=35882064&s=cov&pm=2

Share: http://m.amedeo.com/35882064

2. GANNON WD, Stokes JW, Francois SA, Patel YJ, et al.

Reply to: Extracorporeal membrane oxygenation transport for severe COVID-19 – why

we can and should!

Am J Respir Crit Care Med. 2022 Jul 26. doi: 10.1164/rccm.202207-1415.

PubMed: http://www.amedeo.com/p2.php?id=35882061&s=cov&pm=2

Share: http://m.amedeo.com/35882061

3. PETTENUZZO T, Sella N, Lorenzoni G, Calore A, et al.

The Recruitment-to-Inflation Ratio is Correlated with EIT-Derived Collapse and

Overdistention in COVID-19 ARDS.

Am J Respir Crit Care Med. 2022 Jul 23. doi: 10.1164/rccm.202203-0555.

PubMed: http://www.amedeo.com/p2.php?id=35876133&s=cov&pm=2

Share: http://m.amedeo.com/35876133

4. CHOU R, Dana T, Jungbauer R.

Update Alert 8: Masks for Prevention of Respiratory Virus Infections, Including

SARS-CoV-2, in Health Care and Community Settings.

Ann Intern Med. 2022 Jul 26. doi: 10.7326/L22-0272.

PubMed: http://www.amedeo.com/p2.php?id=35878407&s=cov&pm=2

Share: http://m.amedeo.com/35878407

5. CANTOR AG, Jungbauer RM, Totten AM, Tilden EL, et al.

Telehealth Strategies for the Delivery of Maternal Health Care : A Rapid Review.

Ann Intern Med. 2022 Jul 26. doi: 10.7326/M22-0737.

PubMed: http://www.amedeo.com/p2.php?id=35878405&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35878405

6. SAXENA S, Skirrow H, Wighton K.

Vaccinating children aged under 5 years against covid-19.

BMJ. 2022;378:o1863.

PubMed: http://www.amedeo.com/p2.php?id=35902095&s=cov&pm=2

Share: http://m.amedeo.com/35902095

7. KYE WEN TAN N, Jing-Wen C, Tan, Kye Jyn Tan B, et al.

The burden of prolonged smell and taste loss in covid-19.

BMJ. 2022;378:o1895.

PubMed: http://www.amedeo.com/p2.php?id=35896196&s=cov&pm=2

Share: http://m.amedeo.com/35896196

8. TAN BKJ, Han R, Zhao JJ, Tan NKW, et al.

Prognosis and persistence of smell and taste dysfunction in patients with

covid-19: meta-analysis with parametric cure modelling of recovery curves.

BMJ. 2022;378:e069503.

PubMed: http://www.amedeo.com/p2.php?id=35896188&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35896188

9. DYER C.

Covid-19: “Impossible” to be confident that government awarded Randox contracts

properly, say MPs.

BMJ. 2022;378:o1893.

PubMed: http://www.amedeo.com/p2.php?id=35896187&s=cov&pm=2

Share: http://m.amedeo.com/35896187

10. DAVIES MW.

Learning from complaints during covid-19: discuss risks and benefits before

hospital treatment.

BMJ. 2022;378:o1858.

PubMed: http://www.amedeo.com/p2.php?id=35896182&s=cov&pm=2

Share: http://m.amedeo.com/35896182

11. DE FOO C, Haldane V, Jung AS, Grepin KA, et al.

Isolation facilities for covid-19: towards a person centred approach.

BMJ. 2022;378:e069558.

PubMed: http://www.amedeo.com/p2.php?id=35882391&s=cov&pm=2

Share: http://m.amedeo.com/35882391

12. BULARGA A, Oskoui E, Fujisawa T, Jenks S, et al.

Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19

Vaccination and Infection.

Clin Chem. 2022;68:1015-1019.

PubMed: http://www.amedeo.com/p2.php?id=35896175&s=cov&pm=2

Share: http://m.amedeo.com/35896175

13. KAVSAK PA.

Commentary on Macrotroponin Complex as a Cause for Cardiac Troponin Increase

after COVID-19 Vaccination and Infection.

Clin Chem. 2022;68:1019-1020.

PubMed: http://www.amedeo.com/p2.php?id=35896174&s=cov&pm=2

Share: http://m.amedeo.com/35896174

14. CROAL B.

Commentary on Macrotroponin Complex as a Cause for Cardiac Troponin Increase

after COVID-19 Vaccination and Infection.

Clin Chem. 2022;68:1020-1021.

PubMed: http://www.amedeo.com/p2.php?id=35896173&s=cov&pm=2

Share: http://m.amedeo.com/35896173

15. KOJIMA N, Desai V, Klausner JD.

Distributing Effective SARS-CoV-2 Medicines in a Timely Manner.

J Med Virol. 2022 Jul 26. doi: 10.1002/jmv.28030.

PubMed: http://www.amedeo.com/p2.php?id=35883227&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35883227

16. POURAKBARI B, Mirbeyk M, Mahmoudi S, Sadeghi RH, et al.

Evaluation of response to different COVID-19 vaccines in vaccinated healthcare

workers in a single center in Iran.

J Med Virol. 2022 Jul 26. doi: 10.1002/jmv.28029.

PubMed: http://www.amedeo.com/p2.php?id=35883215&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35883215

17. JANG EJ, Choe YJ, Yun GW, Wang S, et al.

Reinfection with SARS-CoV-2 in general population, South Korea; nationwide

retrospective cohort study.

J Med Virol. 2022 Jul 25. doi: 10.1002/jmv.28026.

PubMed: http://www.amedeo.com/p2.php?id=35879105&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35879105

18. BAUER G, Struck F, Staschik E, Maile J, et al.

Differential avidity determination of IgG directed towards the receptor-binding

domain (RBD) of SARS-CoV-2 wild-type and its variants in one assay: Rational tool

for the assessment of protective immunity.

J Med Virol. 2022 Jul 18. doi: 10.1002/jmv.28006.

PubMed: http://www.amedeo.com/p2.php?id=35851961&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35851961

19. PENG H, Zheng B, Yang S, Du J, et al.

A soluble DR5-Fc chimeric protein (sDR5-Fc) attenuates inflammatory responses

induced by coronavirus MHV-A59 and SARS-CoV-2.

J Med Virol. 2022 Jul 22. doi: 10.1002/jmv.28021.

PubMed: http://www.amedeo.com/p2.php?id=35869417&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35869417

20. WANG X, Zhao X, Cui Y, Qiao R, et al.

Neutralization of Distinct Omicron Sublineages by Longitudinal Vaccination Sera.

J Med Virol. 2022 Jul 22. doi: 10.1002/jmv.28017.

PubMed: http://www.amedeo.com/p2.php?id=35869360&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35869360

21. DU Y, Li W, Guo Y, Li L, et al.

Epidemiology and genetic characterization of human metapneumovirus in pediatric

patients from Hangzhou China.

J Med Virol. 2022 Jul 24. doi: 10.1002/jmv.28024.

PubMed: http://www.amedeo.com/p2.php?id=35871601&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35871601

22. LIU R, Lin X, Chen B, Hou Z, et al.

The mutation features and geographical distributions of the surface glycoprotein

(S gene) in SARS-CoV-2 strains: a comparative analysis of the early and current

strains.

J Med Virol. 2022 Jul 24. doi: 10.1002/jmv.28023.

PubMed: http://www.amedeo.com/p2.php?id=35871556&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35871556

23. KUMAR NP, Banurekha VV, Kumar CPG, Nancy A, et al.

Covaxin induced antibody responses.

J Travel Med. 2022 Jul 28. pii: 6651027. doi: 10.1093.

PubMed: http://www.amedeo.com/p2.php?id=35900009&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35900009

24. HAN C, Ryu S, Shin H, Kim D, et al.

Impact of national lockdown on the suspected SARS-CoV-2 epidemic in terms of the

number of fever cases in North Korea.

J Travel Med. 2022 Jul 28. pii: 6651005. doi: 10.1093.

PubMed: http://www.amedeo.com/p2.php?id=35899877&s=cov&pm=2

Share: http://m.amedeo.com/35899877

25. VINCETI M, Balboni E, Rothman KJ, Teggi S, et al.

Substantial impact of mobility restrictions on reducing COVID-19 incidence in

Italy in 2020.

J Travel Med. 2022 Jul 24. pii: 6649390. doi: 10.1093.

PubMed: http://www.amedeo.com/p2.php?id=35876268&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35876268

26. NORMAN FF, Trevino-Maruri B, Giardin JMR, Gullon-Pena B, et al.

Trends in Imported Malaria during the COVID-19 pandemic, Spain (+Redivi

Collaborative Network).

J Travel Med. 2022 Jul 24. pii: 6649393. doi: 10.1093.

PubMed: http://www.amedeo.com/p2.php?id=35876259&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35876259

27. FROLOVA EI, Palchevska O, Lukash T, Dominguez F, et al.

Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the

Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.

J Virol. 2022 Jul 25:e0075322. doi: 10.1128/jvi.00753.

PubMed: http://www.amedeo.com/p2.php?id=35876526&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35876526

28. DONG S, Kong N, Wang C, Li Y, et al.

FUBP3 Degrades the Porcine Epidemic Diarrhea Virus Nucleocapsid Protein and

Induces the Production of Type I Interferon.

J Virol. 2022;96:e0061822.

PubMed: http://www.amedeo.com/p2.php?id=35695513&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35695513

29. ZENG G.

SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.

JAMA. 2022;328:395.

PubMed: http://www.amedeo.com/p2.php?id=35881131&s=cov&pm=2

Share: http://m.amedeo.com/35881131

30. ULLOA AC, Buchan SA, Brown KA.

SARS-CoV-2 Omicron Variant Severity in Ontario, Canada-Reply.

JAMA. 2022;328:395-396.

PubMed: http://www.amedeo.com/p2.php?id=35881128&s=cov&pm=2

Share: http://m.amedeo.com/35881128

31. SLOMSKI A.

Evusheld Reduces COVID-19 Disease Severity Among Unvaccinated Adults.

JAMA. 2022;328:322.

PubMed: http://www.amedeo.com/p2.php?id=35881125&s=cov&pm=2

Share: http://m.amedeo.com/35881125

32. KUEHN BM.

Persistent Disparities in COVID-19 Antiviral Dispensing.

JAMA. 2022;328:323.

PubMed: http://www.amedeo.com/p2.php?id=35881114&s=cov&pm=2

Share: http://m.amedeo.com/35881114

33. MALANI AG, Malani AN.

Preventive Medication for COVID-19 Infection.

JAMA. 2022 Jul 25. pii: 2794799. doi: 10.1001/jama.2022.13214.

PubMed: http://www.amedeo.com/p2.php?id=35877096&s=cov&pm=2

Share: http://m.amedeo.com/35877096

34. HAUSE AM, Baggs J, Marquez P, Abara WE, et al.

Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged

>/=50 Years – United States, March 29, 2022-July 10, 2022.

MMWR Morb Mortal Wkly Rep. 2022;71:971-976.

PubMed: http://www.amedeo.com/p2.php?id=35900925&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35900925

35. KARAGIANNIS F, Peukert K, Surace L, Michla M, et al.

Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19.

Nature. 2022 Jul 28. pii: 10.1038/s41586-022-05128.

PubMed: http://www.amedeo.com/p2.php?id=35901960&s=cov&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35901960

36. ADAM D.

How long is COVID infectious? What scientists know so far.

Nature. 2022 Jul 26. pii: 10.1038/d41586-022-02026.

PubMed: http://www.amedeo.com/p2.php?id=35883010&s=cov&pm=2

Share: http://m.amedeo.com/35883010

37. YE Y.

China approves first homegrown COVID antiviral.

Nature. 2022 Jul 26. pii: 10.1038/d41586-022-02050.

PubMed: http://www.amedeo.com/p2.php?id=35883009&s=cov&pm=2

Share: http://m.amedeo.com/35883009

38. GUGLIELMI G.

Pandemic drives largest drop in childhood vaccinations in 30 years.

Nature. 2022 Jul 26. pii: 10.1038/d41586-022-02051.

PubMed: http://www.amedeo.com/p2.php?id=35883006&s=cov&pm=2

Share: http://m.amedeo.com/35883006

39. Monkeypox: wealthy countries must avoid their COVID-19 mistakes.

Nature. 2022;607:635-636.

PubMed: http://www.amedeo.com/p2.php?id=35882992&s=cov&pm=2

Share: http://m.amedeo.com/35882992

#Zika Virus Research References (by AMEDEO, July 31 ’22)

1. ZHOU R, Li Q, Yang B, Quan Y, et al.

Repurposing of the antihistamine mebhydrolin napadisylate for treatment of Zika

virus infection.

Bioorg Chem. 2022;128:106024.

PubMed: http://www.amedeo.com/p2.php?id=35901544&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35901544

2. WATTS JL, Ralston A.

The fetal lineage is susceptible to Zika virus infection within days of

fertilization.

Development. 2022;149.

PubMed: http://www.amedeo.com/p2.php?id=35900100&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35900100

3. CIFUENTES MP, Suarez CM, Cifuentes R, Malod-Dognin N, et al.

Big Data to Knowledge Analytics Reveals the Zika Virus Epidemic as Only One of

Multiple Factors Contributing to a Year-Over-Year 28-Fold Increase in

Microcephaly Incidence.

Int J Environ Res Public Health. 2022;19.

PubMed: http://www.amedeo.com/p2.php?id=35897436&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35897436

4. PESCARINI JM, Rodrigues M, Paixao ES, Cardim L, et al.

Dengue, Zika, and Chikungunya viral circulation and hospitalization rates in

Brazil from 2014 to 2019: An ecological study.

PLoS Negl Trop Dis. 2022;16:e0010602.

PubMed: http://www.amedeo.com/p2.php?id=35895718&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35895718

5. GUO Y, Guo J, Li Y, Zheng X, et al.

Wolbachia wPip Blocks Zika Virus Transovarial Transmission in Aedes albopictus.

Microbiol Spectr. 2022 Jul 27:e0263321. doi: 10.1128/spectrum.02633.

PubMed: http://www.amedeo.com/p2.php?id=35894613&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35894613

6. OLIVEIRA MB, Akerman M.

Epistemological disputes in the causal link between Zika virus and congenital

syndrome: a controversy analysis.

Cien Saude Colet. 2022;27:3171-3180.

PubMed: http://www.amedeo.com/p2.php?id=35894328&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35894328

7. MARTIN H, Barthelemy J, Chin Y, Bergamelli M, et al.

Usutu Virus Infects Human Placental Explants and Induces Congenital Defects in

Mice.

Viruses. 2022;14.

PubMed: http://www.amedeo.com/p2.php?id=35893684&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35893684

8. LIN CS, Li WJ, Liao CY, Kan JY, et al.

A Reverse Mutation E143K within the PrM Protein of Zika Virus Asian Lineage Natal

RGN Strain Increases Infectivity and Cytopathicity.

Viruses. 2022;14.

PubMed: http://www.amedeo.com/p2.php?id=35891552&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35891552

9. PEREIRA FM, Salomao de Araujo A, Catarina Martins Reis A, Santos da Hora A, et al.

Dynamics and Determinants of SARS-CoV-2 RT-PCR Testing on Symptomatic Individuals

Attending Healthcare Centers during 2020 in Bahia, Brazil.

Viruses. 2022;14.

PubMed: http://www.amedeo.com/p2.php?id=35891528&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35891528

10. DE VASCONCELOS RAL, Ximenes RAA, Calado AA, Martelli CMT, et al.

Zika-Related Microcephaly and Its Repercussions for the Urinary Tract: Clinical,

Urodynamic, Scintigraphic and Radiological Aspects.

Viruses. 2022;14.

PubMed: http://www.amedeo.com/p2.php?id=35891492&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35891492

11. TORRES FJ, Parry R, Hugo LE, Slonchak A, et al.

Reporter Flaviviruses as Tools to Demonstrate Homologous and Heterologous

Superinfection Exclusion.

Viruses. 2022;14.

PubMed: http://www.amedeo.com/p2.php?id=35891480&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35891480

12. HOWARD FHN, Kwan A, Winder N, Mughal A, et al.

Understanding Immune Responses to Viruses-Do Underlying Th1/Th2 Cell Biases

Predict Outcome?

Viruses. 2022;14.

PubMed: http://www.amedeo.com/p2.php?id=35891472&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35891472

13. MILHIM BHGA, da Rocha LC, Terzian ACB, Mazaro CCP, et al.

Arboviral Infections in Neurological Disorders in Hospitalized Patients in Sao

Jose do Rio Preto, Sao Paulo, Brazil.

Viruses. 2022;14.

PubMed: http://www.amedeo.com/p2.php?id=35891468&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35891468

14. DE OLIVEIRA RIBEIRO G, Gill DE, do Socorro Foro Ramos E, Villanova F, et al.

Chikungunya Virus Asian Lineage Infection in the Amazon Region Is Maintained by

Asiatic and Caribbean-Introduced Variants.

Viruses. 2022;14.

PubMed: http://www.amedeo.com/p2.php?id=35891427&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35891427

15. QUEK JP, Ser Z, Chew BLA, Li X, et al.

Dynamic Interactions of Post Cleaved NS2B Cofactor and NS3 Protease Identified by

Integrative Structural Approaches.

Viruses. 2022;14.

PubMed: http://www.amedeo.com/p2.php?id=35891424&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35891424

16. SINGH K, Martinez MG, Lin J, Gregory J, et al.

Transcriptional and Translational Dynamics of Zika and Dengue Virus Infection.

Viruses. 2022;14.

PubMed: http://www.amedeo.com/p2.php?id=35891396&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35891396

17. TINTO B, Kabore DPA, Kania D, Kagone TS, et al.

Serological Evidence of Zika Virus Circulation in Burkina Faso.

Pathogens. 2022;11.

PubMed: http://www.amedeo.com/p2.php?id=35889987&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35889987

18. FRANCA RKAO, Silva JM, Rodrigues LS, Sokolowskei D, et al.

New Anti-Flavivirus Fusion Loop Human Antibodies with Zika Virus-Neutralizing

Potential.

Int J Mol Sci. 2022;23.

PubMed: http://www.amedeo.com/p2.php?id=35887153&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35887153

19. SANO T, Zhang H, Losakul R, Schmidt H, et al.

All-in-One Optofluidic Chip for Molecular Biosensing Assays.

Biosensors (Basel). 2022;12.

PubMed: http://www.amedeo.com/p2.php?id=35884304&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35884304

20. LI K, Ji Q, Jiang S, Zhang N, et al.

Advancement in the Development of Therapeutics Against Zika Virus Infection.

Front Cell Infect Microbiol. 2022;12:946957.

PubMed: http://www.amedeo.com/p2.php?id=35880081&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35880081

21. DE ALMEIDA PMP, Nobre AA, Camara DCP, Costa LMM, et al.

Dengue, Chikungunya, and Zika: Spatial and Temporal Distribution in Rio de

Janeiro State, 2015-2019.

Trop Med Infect Dis. 2022;7.

PubMed: http://www.amedeo.com/p2.php?id=35878153&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35878153

22. MPONZI WP, Swai JK, Kaindoa EW, Kifungo K, et al.

Observing the distribution of mosquito bites on humans to inform personal

protection measures against malaria and dengue vectors.

PLoS One. 2022;17:e0271833.

PubMed: http://www.amedeo.com/p2.php?id=35877666&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35877666

23. MORAES AG, Ayo CM, Elpidio LNS, Souza VH, et al.

HLA-G, LILRB1 and LILRB2 Variants in Zika Virus Transmission from Mother to Child

in a Population from South and Southeast of Brazil.

Curr Issues Mol Biol. 2022;44:2783-2793.

PubMed: http://www.amedeo.com/p2.php?id=35877415&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35877415

24. VICTORIO CBL, Ong J, Tham JY, Reolo MJ, et al.

Preclinical evaluation of [(18)F]FDG-PET as a biomarker of lymphoid tissue

disease and inflammation in Zika virus infection.

Eur J Nucl Med Mol Imaging. 2022 Jul 25. pii: 10.1007/s00259-022-05892.

PubMed: http://www.amedeo.com/p2.php?id=35876869&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35876869

25. ZHANG Q, Jiang Y, Li C, Gao J, et al.

Survival and Replication of Zika Virus in Diapause Eggs of Aedes Albopictus From

Beijing, China.

Front Microbiol. 2022;13:924334.

PubMed: http://www.amedeo.com/p2.php?id=35875521&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35875521

26. ZHENG J, Yue R, Yang R, Wu Q, et al.

Visualization of Zika Virus Infection via a Light-Initiated Bio-Orthogonal

Cycloaddition Labeling Strategy.

Front Bioeng Biotechnol. 2022;10:940511.

PubMed: http://www.amedeo.com/p2.php?id=35875483&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35875483

27. LEBOV JF, Hooper SR, Pugh N, Becker-Dreps S, et al.

Neurological and neuropsychological sequelae of Zika virus infection in children

in Leon, Nicaragua.

Rev Panam Salud Publica. 2022;46:e90.

PubMed: http://www.amedeo.com/p2.php?id=35875321&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35875321

28. ORGANIZACION PANAMERICANA DE LA SALUD.

[Evidence synthesis: guidelines for diagnosis and treatment of dengue,

chikungunya, and zika in the Region of the AmericasSintese de evidencias:

diretrizes para o diagnostico e o tratamento da dengue, chikungunya e zika na

Regiao das Americas].

Rev Panam Salud Publica. 2022;46:e82.

PubMed: http://www.amedeo.com/p2.php?id=35875317&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35875317

29. WANG X, Chen Y, Shi H, Zou P, et al.

Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly

Inactivating the Virus Particle.

Front Cell Infect Microbiol. 2022;12:905248.

PubMed: http://www.amedeo.com/p2.php?id=35873167&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35873167

30. RAMOS LFC, Martins M, Murillo JR, Domont GB, et al.

Interspecies Isobaric Labeling-Based Quantitative Proteomics Reveals Protein

Changes in the Ovary of Aedes aegypti Coinfected With ZIKV and Wolbachia.

Front Cell Infect Microbiol. 2022;12:900608.

PubMed: http://www.amedeo.com/p2.php?id=35873163&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35873163

31. PANT S, Jena NR.

C-Terminal Extended Hexapeptides as Potent Inhibitors of the NS2B-NS3 Protease of

the ZIKA Virus.

Front Med (Lausanne). 2022;9:921060.

PubMed: http://www.amedeo.com/p2.php?id=35872792&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35872792

32. THOMAS AX, Link N, Robak LA, Demmler-Harrison G, et al.

ANKLE2-related microcephaly: A variable microcephaly syndrome resembling Zika

infection.

Ann Clin Transl Neurol. 2022 Jul 24. doi: 10.1002/acn3.51629.

PubMed: http://www.amedeo.com/p2.php?id=35871307&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35871307

33. CARVALHO DCM, da Silva PG, Dantas WM, da Silva SJR, et al.

Antiviral activity of ouabain against a Brazilian Zika virus strain.

Sci Rep. 2022;12:12598.

PubMed: http://www.amedeo.com/p2.php?id=35871157&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35871157

34. LEVIS M, Ugarte R, Arana M, Ocasio C, et al.

Advancing Leadership Training to Address Health Equity and Respond to Public

Health Emergencies.

J Public Health Manag Pract. 2022;28.

PubMed: http://www.amedeo.com/p2.php?id=35867496&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35867496

35. QIAN XJ, Zhou HY, Liu Y, Dong JX, et al.

Synthesis of baicalein derivatives and evaluation of their antiviral activity

against arboviruses.

Bioorg Med Chem Lett. 2022;72:128863.

PubMed: http://www.amedeo.com/p2.php?id=35738350&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35738350

36. SCHMIDT AM, Freitas LP, Cruz OG, Carvalho MS, et al.

A Poisson-multinomial spatial model for simultaneous outbreaks with application

to arboviral diseases.

Stat Methods Med Res. 2022;31:1590-1602.

PubMed: http://www.amedeo.com/p2.php?id=35658776&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35658776

37. CARDONA-OSPINA JA, Stittleburg V, Millan-Benavidez N, Restrepo-Chica J, et al.

Sensitive and Stable Molecular Detection of Dengue, Chikungunya, and Zika Viruses

from Dried Blood Spots.

Am J Trop Med Hyg. 2022 Jul 5. pii: tpmd211087. doi: 10.4269/ajtmh.21-1087.

PubMed: http://www.amedeo.com/p2.php?id=35895398&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35895398

38. MAGALHAES T, Morais CNL, Azevedo EAN, Jacques IJAA, et al.

Two-year Decay of Zika Virus Neutralizing Antibodies in People Living in an

Endemic Region in Brazil.

Am J Trop Med Hyg. 2022;107:186-189.

PubMed: http://www.amedeo.com/p2.php?id=35895363&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35895363

39. KHOO HY, Lee HY, Khor CS, Tan KK, et al.

Seroprevalence of Zika Virus among Forest Fringe Communities in Peninsular

Malaysia and Sabah: General Population-Based Study.

Am J Trop Med Hyg. 2022 Jul 25. pii: tpmd210988. doi: 10.4269/ajtmh.21-0988.

PubMed: http://www.amedeo.com/p2.php?id=35895331&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35895331

40. FENDERESKI M, Neupane B, Nazneen F, Bai F, et al.

Mouse Trophoblast Cells Can Provide IFN-Based Antiviral Protection to Embryonic

Stem Cells via Paracrine Signaling.

J Immunol. 2022 Jun 1. pii: jimmunol.2100679. doi: 10.4049/jimmunol.2100679.

PubMed: http://www.amedeo.com/p2.php?id=35649628&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35649628

#Influenza and #COVID19 Research References (by AMEDEO, July 30 ’22)

1. DE FOO C, Haldane V, Jung AS, Grepin KA, et al.

Isolation facilities for covid-19: towards a person centred approach.

BMJ. 2022;378:e069558.

PubMed: http://www.amedeo.com/p2.php?id=35882391&s=flu&pm=2

Share: http://m.amedeo.com/35882391

2. WISE J.

Covid-19: Infection raises risk of diabetes and heart disease diagnoses in

following weeks, study finds.

BMJ. 2022;378:o1838.

PubMed: http://www.amedeo.com/p2.php?id=35868645&s=flu&pm=2

Share: http://m.amedeo.com/35868645

3. BEHERA J, Ison J, Voor MJ, Tyagi SC, et al.

Diabetic Covid-19 severity: Impaired glucose tolerance and pathologic bone loss.

Biochem Biophys Res Commun. 2022;620:180-187.

PubMed: http://www.amedeo.com/p2.php?id=35803174&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35803174

4. MISHRA PM, Anjum F, Uversky VN, Nandi CK, et al.

SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human

ACE2 receptors.

Biochem Biophys Res Commun. 2022;620:8-14.

PubMed: http://www.amedeo.com/p2.php?id=35772213&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35772213

5. SEBINA I, Rashid RB, Sikder MAA, Rahman MM, et al.

IFN-lambda Diminishes the Severity of Viral Bronchiolitis in Neonatal Mice by

Limiting NADPH Oxidase-Induced PAD4-Independent NETosis.

J Immunol. 2022;208:2806-2816.

PubMed: http://www.amedeo.com/p2.php?id=35675958&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35675958

6. CHEN Y, Ye Z, Zhang Y, Xie W, et al.

A Deep Learning Model for Accurate Diagnosis of Infection Using Antibody

Repertoires.

J Immunol. 2022;208:2675-2685.

PubMed: http://www.amedeo.com/p2.php?id=35606050&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35606050

7. BRITTO C, Mohorianu I, Yeung T, Cheung E, et al.

Host respiratory transcriptome signature associated with poor outcome in children

with influenza-Staphylococcus aureus pneumonia.

J Infect Dis. 2022 Jul 28. pii: 6650994. doi: 10.1093.

PubMed: http://www.amedeo.com/p2.php?id=35899844&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35899844

8. BI W, Chen G, Dang B.

Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and

Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.

J Virol. 2022 Jun 23:e0068122. doi: 10.1128/jvi.00681.

PubMed: http://www.amedeo.com/p2.php?id=35735997&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35735997

9. CHAN CE, Ng CG, Lim AP, Seah SL, et al.

The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells

Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.

J Virol. 2022 Jun 21:e0045522. doi: 10.1128/jvi.00455.

PubMed: http://www.amedeo.com/p2.php?id=35727030&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35727030

10. LIN J, Law R, Korosec CS, Zhou C, et al.

Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing

Responses for 1 Year Reveals Persistence of Multicytokine Proliferative

Responses, with Greater Immunity Associated with Disease Severity.

J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.

PubMed: http://www.amedeo.com/p2.php?id=35699447&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35699447

11. SUN C, Yuan RY, Xie C, Sun JF, et al.

Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by

S1 Nanoparticle Vaccines.

J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.

PubMed: http://www.amedeo.com/p2.php?id=35699445&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35699445

12. BEACH SS, Hull MA, Ytreberg FM, Patel JS, et al.

Molecular Modeling Predicts Novel Antibody Escape Mutations in the Respiratory

Syncytial Virus Fusion Glycoprotein.

J Virol. 2022;96:e0035322.

PubMed: http://www.amedeo.com/p2.php?id=35678603&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35678603

13. LAVIE M, Dubuisson J, Belouzard S.

SARS-CoV-2 Spike Furin Cleavage Site and S2′ Basic Residues Modulate the Entry

Process in a Host Cell-Dependent Manner.

J Virol. 2022 Jun 9:e0047422. doi: 10.1128/jvi.00474.

PubMed: http://www.amedeo.com/p2.php?id=35678602&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35678602

14. SEVENICH M, van den Heuvel J, Gering I, Mohrluder J, et al.

A So-Far Overlooked Secondary Conformation State in the Binding Mode of

SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for

Estimating Infectivity Efficacy of the Underlying Virus Variant.

J Virol. 2022 Jun 8:e0068522. doi: 10.1128/jvi.00685.

PubMed: http://www.amedeo.com/p2.php?id=35674432&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35674432

15. CHEN X, Li J, Yang L, Zhou Y, et al.

Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification

and Differentiation of Infected from Vaccinated Hosts.

J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.

PubMed: http://www.amedeo.com/p2.php?id=35658531&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35658531

16. ZENG G.

SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.

JAMA. 2022;328:395.

PubMed: http://www.amedeo.com/p2.php?id=35881131&s=flu&pm=2

Share: http://m.amedeo.com/35881131

17. ULLOA AC, Buchan SA, Brown KA.

SARS-CoV-2 Omicron Variant Severity in Ontario, Canada-Reply.

JAMA. 2022;328:395-396.

PubMed: http://www.amedeo.com/p2.php?id=35881128&s=flu&pm=2

Share: http://m.amedeo.com/35881128

18. SLOMSKI A.

Evusheld Reduces COVID-19 Disease Severity Among Unvaccinated Adults.

JAMA. 2022;328:322.

PubMed: http://www.amedeo.com/p2.php?id=35881125&s=flu&pm=2

Share: http://m.amedeo.com/35881125

19. KUEHN BM.

Persistent Disparities in COVID-19 Antiviral Dispensing.

JAMA. 2022;328:323.

PubMed: http://www.amedeo.com/p2.php?id=35881114&s=flu&pm=2

Share: http://m.amedeo.com/35881114

20. SCHWANDT H, Currie J, von Wachter T, Kowarski J, et al.

Changes in the Relationship Between Income and Life Expectancy Before and During

the COVID-19 Pandemic, California, 2015-2021.

JAMA. 2022 Jul 7. pii: 2794146. doi: 10.1001/jama.2022.10952.

PubMed: http://www.amedeo.com/p2.php?id=35797033&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35797033

21. GOGA A, Bekker LG, Garrett N, Reddy T, et al.

Breakthrough SARS-CoV-2 infections during periods of delta and omicron

predominance, South Africa.

Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.

PubMed: http://www.amedeo.com/p2.php?id=35809579&s=flu&pm=2

Share: http://m.amedeo.com/35809579

22. LINK-GELLES R, Levy ME, Gaglani M, Irving SA, et al.

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent

Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages

Predominated – VISION Network, 10 States, December 2021-June 2022.

MMWR Morb Mortal Wkly Rep. 2022;71:931-939.

PubMed: http://www.amedeo.com/p2.php?id=35862287&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35862287

23. KONE A, Horter L, Thomas I, Byrkit R, et al.

Symptoms of Mental Health Conditions and Suicidal Ideation Among State, Tribal,

Local, and Territorial Public Health Workers – United States, March 14-25, 2022.

MMWR Morb Mortal Wkly Rep. 2022;71:925-930.

PubMed: http://www.amedeo.com/p2.php?id=35862276&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35862276

24. HARE BORK R, Robins M, Schaffer K, Leider JP, et al.

Workplace Perceptions and Experiences Related to COVID-19 Response Efforts Among

Public Health Workers – Public Health Workforce Interests and Needs Survey,

United States, September 2021-January 2022.

MMWR Morb Mortal Wkly Rep. 2022;71:920-924.

PubMed: http://www.amedeo.com/p2.php?id=35862270&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35862270

25. VU MN, Lokugamage KG, Plante JA, Scharton D, et al.

QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2

infection and pathogenesis.

Proc Natl Acad Sci U S A. 2022;119:e2205690119.

PubMed: http://www.amedeo.com/p2.php?id=35881779&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35881779

26. XU Z, Choi JH, Dai DL, Luo J, et al.

SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA

translation.

Proc Natl Acad Sci U S A. 2022;119:e2204539119.

PubMed: http://www.amedeo.com/p2.php?id=35878012&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35878012

27. GUO K, Barrett BS, Morrison JH, Mickens KL, et al.

Interferon resistance of emerging SARS-CoV-2 variants.

Proc Natl Acad Sci U S A. 2022;119:e2203760119.

PubMed: http://www.amedeo.com/p2.php?id=35867811&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35867811

28. IOANNIDIS JPA, Bendavid E, Salholz-Hillel M, Boyack KW, et al.

Massive covidization of research citations and the citation elite.

Proc Natl Acad Sci U S A. 2022;119:e2204074119.

PubMed: http://www.amedeo.com/p2.php?id=35867747&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35867747

29. HAN M, Gao S, Hu W, Zhou Q, et al.

Inhibitory effects of cedar pine needle extract on H9N2 avian influenza virus in

vitro and in vivo.

Virology. 2022;574:25-36.

PubMed: http://www.amedeo.com/p2.php?id=35878455&s=flu&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35878455

Multi-country #outbreak of #monkeypox – External #Situation #Report 2, published 25 July 2022 (@WHO, excerpts)


Source: World Health Organization, full PDF file {external URL: https://www.who.int/publications/m/item/multi-country-outbreak-of-monkeypox–external-situation-report–2—25-july-2022}

Data as received by WHO national authorities by 17:00 CEST, 22 July 2022


Highlights

  • The International Health Regulations Emergency Committee on the multi-country outbreak of monkeypox held its second meeting on 21 July 2022. Having considered the views of Committee Members and Advisors as well as other factors in line with the International Health Regulations (2005), the WHO Director-General on 23 July 2022 declared this outbreak a public health emergency of international concern and issued Temporary Recommendations in relation to the outbreak. He stated that “we have an outbreak that has spread around the world rapidly, through new modes of transmission, about which we understand too little, and which meets the criteria in the International Health Regulations…(T)his is an outbreak that can be stopped with the right strategies in the right groups.” He issued temporary recommendations for countries to stop transmission and bring the outbreak under control.ù
  • All six WHO Regions have now reported cases of monkeypox. Since the situation report published on 6 July, the South-East Asia Region reported confirmed cases.
  • In the African Region, the latest data on monkeypox indicate a significant increase in cases since April 2022, compared to the same period in 2021, which could, in part, be attributed to enhanced monkeypox surveillance and laboratory testing capacity in the countries. The highest number of suspected cases of monkeypox in the region had been reported in 2020.
  • WHO has launched a global epidemiological report titled “Multi-Country Monkeypox Outbreak – Global Trends” that is updated at least twice weekly, and the geographic distribution of cases can be viewed using the WHO Health Emergency Dashboard. The Report focuses on case report forms provided by the Member States to WHO, as outlined in the Surveillance, case investigation, and contact tracing for Monkeypox interim guidance. The Dashboard provides the latest aggregate cases and deaths reported by the Member States, updated daily. These two data products complement this Situation Report, which is produced every two weeks and provides a more comprehensive update of the monkeypox outbreak beyond the epidemiological information; and which itself is a successor of the previous Disease Outbreak News reports on monkeypox.
  • The information on the Dashboard can be accessed through the left-hand menu tabs:
  • o Under LAYERS: case data per country can be viewed by clicking on a specific country on the interactive map.
  • o Under SUMMARY: the total cumulative numbers of cases and deaths, globally and by region, and the newly reported cases in the last seven days.

Risk assessment

Global risk – Moderate

WHO Regional risk

• European Region – High

• African Region, Region of the Americas, Eastern Mediterranean Region,

Southeast Asia Region – Moderate

• Western Pacific Region – Low-Moderate

(…)

——

#Zika Virus Research References (by AMEDEO, July 24 ’22)

1. ZHU G, Shi Y, Li Y, Xiao G, et al.

Model-Based Projection of Zika Infection Risk with Temperature Effect: A Case

Study in Southeast Asia.

Bull Math Biol. 2022;84:92.

PubMed: http://www.amedeo.com/p2.php?id=35864431&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35864431

2. OEYEN M, Meyen E, Doijen J, Schols D, et al.

In-Depth Characterization of Zika Virus Inhibitors Using Cell-Based Electrical

Impedance.

Microbiol Spectr. 2022 Jul 11:e0049122. doi: 10.1128/spectrum.00491.

PubMed: http://www.amedeo.com/p2.php?id=35862960&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35862960

3. COISH JM, Crozier RWE, Schieffelin JS, Coorssen JR, et al.

Zika Virus Replication in a Mast Cell Model is Augmented by Dengue Virus

Antibody-Dependent Enhancement and Features a Selective Immune Mediator Secretory

Profile.

Microbiol Spectr. 2022 Jul 5:e0177222. doi: 10.1128/spectrum.01772.

PubMed: http://www.amedeo.com/p2.php?id=35862953&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35862953

4. PERROTTA D, Frias-Martinez E, Pastore Y Piontti A, Zhang Q, et al.

Comparing sources of mobility for modelling the epidemic spread of Zika virus in

Colombia.

PLoS Negl Trop Dis. 2022;16:e0010565.

PubMed: http://www.amedeo.com/p2.php?id=35857744&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35857744

5. SALMERON ACA, Bezerra WP, de Souza RLL, Pereira LC, et al.

Immunological imbalance in microcephalic children with congenital Zika virus

syndrome.

Med Microbiol Immunol. 2022 Jul 20. pii: 10.1007/s00430-022-00746.

PubMed: http://www.amedeo.com/p2.php?id=35857104&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35857104

6. MORRIS M, Brito A, Malta M, Jacques I, et al.

Experiences of women raising children with congenital Zika syndrome along a

trajectory of prevention, care and support in Brazil.

Glob Public Health. 2022 Jul 18:1-15. doi: 10.1080/17441692.2022.2098999.

PubMed: http://www.amedeo.com/p2.php?id=35849617&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35849617

7. LI Z, Xu J, Lang Y, Wu X, et al.

In vitro and in vivo characterization of erythrosin B and derivatives against

Zika virus.

Acta Pharm Sin B. 2022;12:1662-1670.

PubMed: http://www.amedeo.com/p2.php?id=35847519&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35847519

8. HORA LCDD, Muniz LF, Griz SMS, Silva JDD, et al.

Frequency-Following Response and Auditory Behavior in Children with Prenatal

Exposure to the Zika Virus.

Int Arch Otorhinolaryngol. 2021;26:e380-e389.

PubMed: http://www.amedeo.com/p2.php?id=35846828&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35846828

9. TAFESH-EDWARDS G, Kalukin A, Eleftherianos I.

Zika Virus Induces Sex-Dependent Metabolic Changes in Drosophila melanogaster to

Promote Viral Replication.

Front Immunol. 2022;13:903860.

PubMed: http://www.amedeo.com/p2.php?id=35844546&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35844546

10. DARAI N, Mahalapbutr P, Wolschann P, Lee VS, et al.

Theoretical studies on RNA recognition by Musashi 1 RNA-binding protein.

Sci Rep. 2022;12:12137.

PubMed: http://www.amedeo.com/p2.php?id=35840700&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35840700

11. FERNANDES S, Pinto M, Barros L, Moreira MEL, et al.

The economic burden of congenital Zika Syndrome in Brazil: an overview at 5 years

and 10 years.

BMJ Glob Health. 2022;7.

PubMed: http://www.amedeo.com/p2.php?id=35840168&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35840168

12. CHANG KT, Snead MC, Serrano Rodriguez RA, Bish C, et al.

Condom use among women of reproductive age (18-49 years) in Puerto Rico during

the 2016 Zika virus outbreak: secondary analysis of data from a cross-sectional,

population-based, cell-phone survey.

BMJ Open. 2022;12:e065592.

PubMed: http://www.amedeo.com/p2.php?id=35835533&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35835533

13. DUDLEY DM, Koenig MR, Stewart LM, Semler MR, et al.

Human immune globulin treatment controls Zika viremia in pregnant rhesus

macaques.

PLoS One. 2022;17:e0266664.

PubMed: http://www.amedeo.com/p2.php?id=35834540&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35834540

14. BLIMAN PA, Dumont Y.

Robust control strategy by the Sterile Insect Technique for reducing

epidemiological risk in presence of vector migration.

Math Biosci. 2022;350:108856.

PubMed: http://www.amedeo.com/p2.php?id=35691589&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35691589

15. POVEDA-CUEVAS SA, Etchebest C, Barroso da Silva FL.

Self-association features of NS1 proteins from different flaviviruses.

Virus Res. 2022;318:198838.

PubMed: http://www.amedeo.com/p2.php?id=35662566&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35662566

16. PLUVIANO S, Watt C, Pompeia S, Ekuni R, et al.

Forming and updating vaccination beliefs: does the continued effect of

misinformation depend on what we think we know?

Cogn Process. 2022;23:367-378.

PubMed: http://www.amedeo.com/p2.php?id=35583578&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35583578

17. KIRSTEIN OD, Talavera GA, Wei Z, Ciau-Carrilo KJ, et al.

Natural Aedes-Borne Virus Infection Detected in Male Adult Aedes aegypti

(Diptera: Culicidae) Collected From Urban Settings in Merida, Yucatan, Mexico.

J Med Entomol. 2022;59:1336-1346.

PubMed: http://www.amedeo.com/p2.php?id=35535688&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35535688

18. OUTAMMASSINE A, Zouhair S, Loqman S.

Global potential distribution of three underappreciated arboviruses vectors

(Aedes japonicus, Aedes vexans and Aedes vittatus) under current and future

climate conditions.

Transbound Emerg Dis. 2022;69:e1160-e1171.

PubMed: http://www.amedeo.com/p2.php?id=34821477&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/34821477

19. LESLIE M.

Dengue and zika viruses turn people into mosquito bait.

Science. 2022;377:137.

PubMed: http://www.amedeo.com/p2.php?id=35857561&s=zik&pm=2

ABSTRACT available

Share: http://m.amedeo.com/35857561